Allegheny County, Pa., funds by Health and Human Services, Department of
Listing $221,293,164.81 in stimulus funds from Health and Human Services, Department of for Allegheny
Note: For some programs where states do not report where money will be distributed across the state, we do not have the allocation for individual counties. Those programs include: Medicaid, unemployment benefits and food stamps. Those amounts are included in the totals for where the state agency receiving that money is located.
Amount refers to both the amount of stimulus funding going toward the project and the face value of the loan.
Recipient | Amount | Description | Federal Dept./Agency | Date |
---|---|---|---|---|
UNIVERSITY OF PITTSBURGH THE | $13,986,243 | National Center for Research Resources, Recovery Act Construction Support The specific aim of this application for funds is to renovate 44,525 GSF of space on the 12th floor of the Thomas E. Starzl Biomedical Science Tower (BST) to accommodate the Vascular Medicine Institute and the Division of Pulmomonary, Allergy, and Critical ... Show more | National Institutes of Health | 3/31/2010 |
PITTSBURGH REGIONAL HEALTHCARE INITIATIVE | $7,311,114 |
ARRA - Health Information Technology Extension Program This program provides grants for the establishment of Health Information Technology Regional Extension Centers that will offer technical assistance, guidance and information on best practices to support and accelerate health care providersG?? efffforts to b... Show more
This spending item is part of a $11,581,159 allocation.
See details
|
Health and Human Services, Department of | 3/31/2010 |
UNIVERSITY OF PITTSBURGH THE | $3,001,400 | To establish a Tissue Source Site (TSS) Network capable of delivering clinically annotated biospecimens through either or both retrospective and prospective collections. The tissues and clinical data will be delivered to one of the TCGA's Biospecimen Core | National Institutes of Health | 9/28/2010 |
UNIVERSITY OF PITTSBURGH THE | $2,934,725 | Trans-NIH Recovery Act Research Support UPCI plans to further develop the Clinical Disease Site Programs. To develop translational research of these programs, UPCI intends to recruit new translationally-oriented physician-scientist faculty members and support their career development. The Admin | National Institutes of Health | 9/21/2009 |
UNIVERSITY OF PITTSBURGH THE | $2,815,428 | Trans-NIH Recovery Act Research Support Our overarching hypothesis is that liver non-parenchymal, antigen-presenting cells (APC) serve as key regulators of hepatic-based inflammatory/immune responses. This Program Project brings together the collective expertise of a highly-experienced and inte | National Institutes of Health | 9/01/2009 |
UNIVERSITY OF PITTSBURGH THE | $2,688,777 | Trans-NIH Recovery Act Research Support This funded grant application provides funds for a Siemens Eclipse HP Cyclotron in support of a highly successful positron emission tomography (PET) imaging research program that has been operational at the University of Pittsburgh since 1992. This resear | National Institutes of Health | 2/20/2010 |
UNIVERSITY OF PITTSBURGH THE | $2,590,638 |
Trans-NIH Recovery Act Research Support As life expectancy in the United States continues to rise, the maintenance of physical independence among older Americans has emerged as a major clinical and public health priority. Efficient and reliable locomotion, or the ability to move without assista
This spending item is part of a $29,648,216 allocation.
See details
|
National Institutes of Health | 9/24/2009 |
CARNEGIE MELLON UNIVERSITY | $2,584,852 |
Trans-NIH Recovery Act Research Support INNOVATIVE SUPERCOMPUTING FOR BREAKTHROUGH MOLECULAR DYNAMICS ABSTRACT A partnership between D.E. Shaw Research (DESRES) and the National Resource for Biomedical Supercomputing (NRBSC) at the Pittsburgh Supercomputing Center (PSC) will enable breakthrough
This spending item is part of a $2,657,497 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
ALLEGHENY, COUNTY OF | $2,416,857 |
ARRA - Community Services Block Grant Funds are awarded to the existing network of Community Action Agencies, who must receive 99% of the funds appropriated. Funds are to be used for activities serving the population at or below 200% of the federal poverty level, as established by the Office
This spending item is part of a $42,332,166 allocation.
See details
|
Administration for Children and Families | 4/10/2009 |
UNIVERSITY OF PITTSBURGH THE | $2,272,500 | Trans-NIH Recovery Act Research Support Regenerative medicine largely relies on cell-based therapy for treatment of degenerative diseases such as diabetes, heart failure, and Parkinson's disease. Embryonic stem cells and recently established induced pluripotent stem cells will be able to contri | National Institutes of Health | 9/30/2009 |
UNIVERSITY OF PITTSBURGH THE | $2,213,938 |
Trans-NIH Recovery Act Research Support The representation of minorities in public health and biomedical research still lags behind that of whites. This represents an ongoing challenge to the validity and generalizability of research findings, which consequently contributes to disparities in h
This spending item is part of a $2,941,900 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
UNIVERSITY OF PITTSBURGH THE | $2,201,163 |
Trans-NIH Recovery Act Research Support Chronic lung diseases represent a broad spectrum of chronic fibrosing/inflammatory lung conditions that are for the most part poorly responsive to treatment and often fatal. COPD/emphysema is the fourth leading cause of death in the United States and the
This spending item is part of a $9,746,871 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
PSYCHOLOGY SOFTWARE TOOLS, INC. | $2,101,646 |
Trans-NIH Recovery Act Research Support DESCRIPTION (provided by applicant): Cognitive dysfunction in the elderly population, ranging from simple forgetfulness to a diagnosis of Alzheimer's disease, can impact one's quality of life and ability to function in daily activities. It is crucial that
This spending item is part of a $2,305,646 allocation.
See details
|
National Institutes of Health | 5/26/2010 |
UNIVERSITY OF PITTSBURGH THE | $2,000,000 | Trans-NIH Recovery Act Research Support A clinical animal MR imager designed for translational research: the 7T Clinscan Summary: The purpose of this American Reinvestment and Recovery Act (ARRA) award is to provide funds towards the purchase of a small animal clinical magnetic resonance (MR) | National Institutes of Health | 4/28/2009 |
UNIVERSITY OF PITTSBURGH THE | $1,989,283 |
Trans-NIH Recovery Act Research Support A recent Agency for Healthcare Research and Quality (AHRQ) executive summary indicated that better systems are needed to determine the relative merits of existing versus new and expensive biologic drug therapies for rheumatoid arthritis (RA). Research tha
This spending item is part of a $2,707,443 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
UNIVERSITY OF PITTSBURGH THE | $1,947,686 | Recovery Act Comparative Effectiveness Research - AHRQ The proposed grant will support an early career development program involving clinical investigators from the six Schools of the Health Sciences at the University of Pittsburgh and the University of Pittsburgh Medical Center (UPMC). It is designgned to dev... Show more | Agency for Healthcare Research and Quality | 7/01/2010 |
PITTSBURGH COMMUNITY SERVICES, INC. | $1,863,331 |
ARRA - Community Services Block Grant Funds are awarded to the existing network of Community Action Agencies, who must receive 99% of the funds appropriated. Funds are to be used for activities serving the population at or below 200% of the federal poverty level, as established by the Office
This spending item is part of a $42,332,166 allocation.
See details
|
Administration for Children and Families | 4/10/2009 |
UNIVERSITY OF PITTSBURGH THE | $1,827,909 |
Trans-NIH Recovery Act Research Support In previous work, we have developed, deployed and evaluated a novel intelligent medical training system for pathologic diagnosis and reporting. SlideTutor is an individualized, adaptive, simulation environment that provides explanations and assistance spe
This spending item is part of a $1,901,894 allocation.
See details
|
National Institutes of Health | 5/27/2009 |
UNIVERSITY OF PITTSBURGH THE | $1,817,459 | Trans-NIH Recovery Act Research Support Older adults exhibit considerable heterogeneity of immune and health phenotypes. Many of them are surviving well beyond the median lifespan of many populations and have exceptional health and performance. Healthy aging is likely to be dependent on unique | National Institutes of Health | 9/04/2009 |
PITTSBURGH REGIONAL HEALTHCARE INITIATIVE | $1,626,286 |
Recovery Act Comparative Effectiveness Research - AHRQ Title: Implementing Behavioral Health in Primary Care by Leveraging AHRQ Networks Behavioral health problems are among the most prevalent of health problems in the United States and are directly related to poor healthcare quality and higher utililization o... Show more
This spending item is part of a $3,421,521 allocation.
See details
|
Agency for Healthcare Research and Quality | 9/28/2010 |
UNIVERSITY OF PITTSBURGH THE | $1,530,864 | ARRA Prevention Research Centers Comparative Effectiveness Research Program Statement of the problem: The CDC Web-based Injury Statistics Query and Reporting System (WISQRS) shows the high prevalence of serious fall-related injuries, defined as need for hospitalization or medical care: in 2006, the m most recent data available, the... Show more | Centers for Disease Control and Prevention | 7/14/2010 |
UNIVERSITY OF PITTSBURGH THE | $1,514,238 | Trans-NIH Recovery Act Research Support We reported on a limited number of cases that SIVagm infection is completely controlled in rhesus macaques (RMs). Our preliminary results showed that although acute SIVagm infection in RMs is characterized by: high levels of viral replication, and dramati | National Institutes of Health | 9/26/2009 |
ALLEGHENY INTERMEDIATE UNIT 3 | $1,496,840 | ARRA - Early Head Start The Early Head Start (EHS) grant will serve 72 children (zero to three) in a home based model (64 Children) and Center Based Model (8) in three communities, South Hills, West View and Carnegie, of Allegheny County. The EHS program is for low-income infan | Administration for Children and Families | 2/24/2010 |
UNIVERSITY OF PITTSBURGH THE | $1,469,550 | Trans-NIH Recovery Act Research Support The strategy was decided to build research capabilities on the existing tissue engineering strengths at the University of Pittsburgh which was lacking a concerted effort in the field of craniofacial regeneration. During its short history, CCR has been gro | National Institutes of Health | 9/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $1,453,652 | Trans-NIH Recovery Act Research Support This project aims to support the hiring of a new tenure track Assistant Professor to perform research on vascular disease and pulmonary hypertension complications in patients with systemic sclerosis (SSc) in an interdisciplinary environment, focusing on t | National Institutes of Health | 9/23/2009 |
UNIVERSITY OF PITTSBURGH THE | $1,452,921 | Trans-NIH Recovery Act Research Support Primary lymphedema is the clinical expression of defects in lymphatic development and function. Three genes have been shown to cause primary lymphedema, VEGFR3, FOXC2 and SOX18. Mutations in these genes account for only a fraction (~1/3) of all cases of p | National Institutes of Health | 9/10/2009 |
UNIVERSITY OF PITTSBURGH THE | $1,413,993 |
Trans-NIH Recovery Act Research Support Acute kidney injury (AKI) has a high mortality and morbidity that has not decreased over the last twenty years. Since innate renal tubular regeneration occurs after tissue injury, there has been considerable interest in the development of treatments that
This spending item is part of a $2,788,277 allocation.
See details
|
National Institutes of Health | 9/29/2010 |
UNIVERSITY OF PITTSBURGH THE | $1,411,633 |
Trans-NIH Recovery Act Research Support Racial disparities exist in cardiovascular disease (CVD), with blacks having more prevalent and severe CVD compared to whites, independent of race-related differences in CVD risk factors. Despite having higher rates of CVD, blacks are less likely than whi
This spending item is part of a $1,538,421 allocation.
See details
|
National Institutes of Health | 8/14/2009 |
BOARD OF PUBLIC EDUCATION SCHOOL DISTRICT OF PITTSBURGH (INC) | $1,355,325 | ARRA - Early Head Start Award Title: Early Head Start ARRA Expansion The Early Head Start ARRA Expansion award provides funding for the Pittsburgh School District Early Childhood Program to serve 36 children in child care centers and 36 children in a home-based setting (72 chil | Administration for Children and Families | 11/18/2009 |
UNIVERSITY OF PITTSBURGH THE | $1,327,540 | Trans-NIH Recovery Act Research Support The overarching goal of this P30 application is to enhance research capacity in the understanding and treatment of cardiovascular, pulmonary, and blood diseases, and other biomedical and translational research areas through the development of stem cell re | National Institutes of Health | 9/25/2009 |
NORTH SIDE CHRISTIAN HEALTH CENTER | $1,300,000 | ARRA Health Center Integrated Services Development Initiative[g1] In March 2009, North Side Christian Health Care Center (NSCHC) was awarded New Access Points in Programs Funded Under the Health Centers Consolidation Act of 1996, CFDA Number 93.224, for Section 330(e), 330(h), and 330(i) funding. Witith the two grant appr... Show more | Health Resources and Services Administration | 2/26/2009 |
NORTH SIDE CHRISTIAN HEALTH CENTER | $1,300,000 | ARRA Health Center Integrated Services Development Initiative[g1] In March 2009, North Side Christian Health Care Center (NSCHC) was awarded New Access Points in Programs Funded Under the Health Centers Consolidation Act of 1996, CFDA Number 93.224, for Section 330(e), 330(h), and 330(i) funding. Witith the two grant appr... Show more | Health Resources and Services Administration | 2/26/2009 |
UNIVERSITY OF PITTSBURGH THE | $1,299,870 | Trans-NIH Recovery Act Research Support Dengue virus (DENV) infection of humans has steadily increased in importance as an emerging infectious disease, and the development of protective vaccines to DENV disease has been impeded by a lack of understanding of virus-specific immune responses and t | National Institutes of Health | 9/28/2009 |
UNIVERSITY OF PITTSBURGH THE | $1,260,025 | Trans-NIH Recovery Act Research Support Multicenter AIDS Cohort Study (MACS): Role of viral coinfections in HIV-1 disease progression in the MACS The overall objective of this proposal is to obtain a comprehensive dataset on herpesvirus and GB virus type C (GBV-C) load in blood and other body | National Institutes of Health | 9/21/2009 |
UNIVERSITY OF PITTSBURGH THE | $1,237,901 |
Trans-NIH Recovery Act Research Support Project 1: The development of new ideas and approaches to understanding the mechanisms of natural HIV-1 resistance. In collaboration with the University of Washington, we hypothesize that HIV-1 infection in high risk seronegatives (HRSN) is below the dete
This spending item is part of a $2,221,266 allocation.
See details
|
National Institutes of Health | 5/03/2010 |
UNIVERSITY OF PITTSBURGH THE | $1,201,412 | Trans-NIH Recovery Act Research Support The Aim of the Program Plan that is the basis of this application is to expand the breadth of research expertise and research programs in the Center for Pain Research at the University of Pittsburgh. Center faculty members have identified two broad areas | National Institutes of Health | 9/25/2009 |
UNIVERSITY OF PITTSBURGH THE | $1,200,000 | Trans-NIH Recovery Act Research Support This study will evaluate, by a randomized clinical trial, two models of care for type 1 diabetes (youth onset) in the developing world (Rwanda), including their comparative costs. This type of diabetes poses severe challenges to the children and their pa | National Institutes of Health | 9/30/2010 |
UNIVERSITY OF PITTSBURGH THE | $1,162,288 | Trans-NIH Recovery Act Research Support Predicting Patient Outcomes from Clinical and Genome-Wide Data Clinical classification and prediction are key components of clinical care. Even modest improvements in classification and predictive performance may have significant healthcare consequences | National Institutes of Health | 6/08/2009 |
UNIVERSITY OF PITTSBURGH THE | $1,149,443 |
Trans-NIH Recovery Act Research Support Research to be conducted under the ARRA mechanism will accelerate the scientific tempo of a trial designed to understand the efficacy, mechanisms, and cost-effectiveness of alternative resuscitation strategies for septic shock. Trial recruitment will be e
This spending item is part of a $2,314,994 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
PRIMARY CARE HEALTH SERVICES INC | $1,128,290 | ARRA Health Center Integrated Services Development Initiative[g1] CIP funds awarded are being used to renovate several Community Health Centers (painting, carpeting), procure and/or upgrade dental equipment, enhance space and improve access for patient care. Replace heating and cooling systems for t the comfprt of health... Show more | Health Resources and Services Administration | 6/25/2009 |
CHATHAM UNIVERSITY | $1,113,542 | ARRA Grants for Training in Primary Care Medicine and Dentistry Training and Enhancement The name of the award is: ARRA-Training in Primary Care Medicine and Dentistry: Physician Assistant Training in Primary Care. The purpose of this award is to provide Chatham University wih resources to increase t the numbers of gradutating Physicians Assist... Show more | Health Resources and Services Administration | 9/03/2010 |
Young Women's Christian Association of Greater Pittsburgh | $1,071,053 |
ARRA Child Care and Development Block Grant The American Recovery and Reinvestment Act (ARRA) Child Care and Development Fund (CCDF) funds have two mandatory earmarks, Infant/Toddler and Quality. The Infant/Toddler funds are utilized for new center-based Keystone Babies programs. Specifically, th
This spending item is part of a $60,146,767 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
UNIVERSITY OF PITTSBURGH THE | $1,041,647 | Trans-NIH Recovery Act Research Support BMI Training Program is requesting the addition of three predoctoral and five postdoctoral funded slots. The addition of the eight requested additional slots is consistent with the goals of ARRA funding to 'preserve and create jobs and promote economic re | National Institutes of Health | 8/20/2009 |
UNIVERSITY OF PITTSBURGH THE | $1,008,876 |
Trans-NIH Recovery Act Research Support Despite our ability to identify risk factors that may increase the likelihood of acquiring Alzheimer's (such as age, family history, and some possible genetic markers), we cannot identify with certainty those who will develop this disease. A research grou
This spending item is part of a $1,691,538 allocation.
See details
|
National Institutes of Health | 8/14/2009 |
UNIVERSITY OF PITTSBURGH THE | $1,000,000 | Trans-NIH Recovery Act Research Support This project will address the lack of randomized controlled studies and comparative effectiveness research in bariatric surgery by utilizing a three arm randomized trial to compare medical and surgical treatments for Type 2 diabetes. Understanding more c | National Institutes of Health | 9/25/2009 |
UNIVERSITY OF PITTSBURGH THE | $999,999 | Trans-NIH Recovery Act Research Support Aim of the Supplement Project: To develop a state of the art Clinical and Translational Vascular Unit (CTVU) to provide a comprehensive assessment of pulmonary and peripheral endothelial function, blood flow, subclinical atherosclerotic disease, and righ | National Institutes of Health | 9/09/2009 |
UNIVERSITY OF PITTSBURGH THE | $999,180 | Trans-NIH Recovery Act Research Support This study explores the redox reactions of nitrite and how fatty acid nitro derivatives might transduce salutary actions of dietary and endogenously-produced nitrite. In particular, preliminary studies have shown that nitro-fatty acids lower blood glucose | National Institutes of Health | 9/25/2009 |
UNIVERSITY OF PITTSBURGH THE | $997,916 | Trans-NIH Recovery Act Research Support The proposed supplement will substantially enhance the ability of the CTSA at the University of Pittsburgh to foster and conduct comparative effectiveness research, which will improve the translation of scientific discovery into clinical use, and provide | National Institutes of Health | 9/29/2009 |
UNIVERSITY OF PITTSBURGH THE | $994,844 |
Trans-NIH Recovery Act Research Support Making HIV testing routine is one of the major HIV prevention strategies in the United States. The Centers for Disease Control and Prevention recently recommended that prevention counseling not be required as part of HIV screening programs in medical care
This spending item is part of a $12,292,823 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
UNIVERSITY OF PITTSBURGH THE | $992,870 | Trans-NIH Recovery Act Research Support The purpose of this clinical trial is to study the effectiveness of a weight management intervention for pediatric obesity adapted for a low income, racially and ethnically diverse disparity population on child BMI in a sample of 140 obese children ages 2 | National Institutes of Health | 9/24/2009 |
UNIVERSITY OF PITTSBURGH THE | $985,762 | Trans-NIH Recovery Act Research Support Psychiatric Disorders such as alcohol/substance abuse disorders, depression, bipolar disorder and impulsivity-related disorders such as ADHD are among the most significant causes of illness and death in the USA (together affect at least 17 percent of the | National Institutes of Health | 9/30/2009 |
UNIVERSITY OF PITTSBURGH THE | $970,117 | Trans-NIH Recovery Act Research Support The liver performs over 3,000 functions critical to maintaining the organism, ranging from production and secretion of proteins such as albumin, clotting factors and antiproteases, to metabolism and excretion of exogenous compounds such as drugs or toxins | National Institutes of Health | 9/29/2009 |
UNIVERSITY OF PITTSBURGH THE | $969,829 |
Trans-NIH Recovery Act Research Support This proposal addresses Challenge area 7: Enhancing Clinical Trials: 07-OD(ORDR)-102 for the development of a rare disease genetic patient registry. Peripartum cardiomyopathy (PPCM) is a complication of pregnancy occurring in 1:1800 to 1:3500 births in th
This spending item is part of a $999,818 allocation.
See details
|
National Institutes of Health | 9/21/2009 |
CARNEGIE MELLON UNIVERSITY | $948,648 | Trans-NIH Recovery Act Research Support This application addresses broad Challenge Area (01): Behavior, Behavioral Change, and Prevention, and specific Challenge Topic 03-MH-101: Biomarkers in Mental Disorders. Clinically significant depressive symptoms have been reported in up to 86% of nursin | National Institutes of Health | 9/24/2009 |
UNIVERSITY OF PITTSBURGH THE | $940,655 |
Trans-NIH Recovery Act Research Support Advances in basic science research over the past 20 years have created new opportunities for targeted therapies for TBI, but such advances have failed to translate into successful clinical trials or treatments. Improving the quality of healthcare delivery
This spending item is part of a $4,131,403 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
COMMUNITY HUMAN SERVICES CORP | $924,633 |
ARRA - Early Head Start The University of Pittsburgh Office of Child Development will provide Early Head Start services to families with infant and toddlers. The model is primarily home-based with children within Allegheny County. The primary communities are the city of Clairton
This spending item is part of a $2,639,588 allocation.
See details
|
Administration for Children and Families | 11/19/2009 |
UNIVERSITY OF PITTSBURGH THE | $911,922 | Trans-NIH Recovery Act Research Support A controversial component of the Medicare Prescription Drug Benefit (Part D) enacted in 2006 is the doughnut hole, a gap in coverage for pharmacy expenditures between $2,250 and $5,100. We recently reported that one in four seniors entered the doughnut ho | National Institutes of Health | 9/24/2009 |
UNIVERSITY OF PITTSBURGH THE | $909,000 | Trans-NIH Recovery Act Research Support Incomplete healing of bone defects in the craniofacial skeleton is common. Osteogenic proteins, including bone morphogenetic protein 2 and 4 (BMP2, BMP4), promote healing in bone defects, but the proteins' short half-lives and rapid clearance by the blood | National Institutes of Health | 9/01/2009 |
UNIVERSITY OF PITTSBURGH THE | $901,232 | Trans-NIH Recovery Act Research Support The proportion of persons living with HIV/AIDS who are over 50 rose to 22.5% of all cases in 2004, and with the increasing use of Highly Active Antiretroviral Therapy (HAART), more than nearly three-quarters of HIV-infected individuals over 50 now die fro | National Institutes of Health | 9/11/2009 |
UNIVERSITY OF PITTSBURGH THE | $900,266 | Trans-NIH Recovery Act Research Support The Hepatoprotective Role of the Orphan Nuclear Receptor LXR The liver X receptors (LXRs) are transcriptional factors highly expressed in the liver. The goal of this study is to determine whether LXRs play a hepatoprotective role in preventing toxicity f | National Institutes of Health | 8/25/2009 |
UNIVERSITY OF PITTSBURGH THE | $886,790 | In vitro screening of combinations to treat cancer. The Work Assignment (WA) for N01-CM-52202 (Julie Eiseman, PI) has three separate phases: the Pilot Phase (3 months), the Production Phase (12 months) and Data Analysis Phase (3 months). We will use a | National Institutes of Health | 9/19/2010 |
UNIVERSITY OF PITTSBURGH THE | $886,708 | Trans-NIH Recovery Act Research Support One-half of all depressed patients present for treatment with serious and distressing symptoms of anxiety or panic. Patients whose depression is complicated by co-existing anxiety features display a more severe and recurrent form of depression, poorer wor | National Institutes of Health | 5/05/2009 |
UNIVERSITY OF PITTSBURGH THE | $853,479 |
Trans-NIH Recovery Act Research Support Severe asthma, a heterogeneous disease consisting of related clinical phenotypes, generates high levels of morbidity, mortality and health care costs. The complexity and heterogeneity of the disorder have limited clinical advances. However, the NHLBI Seve
This spending item is part of a $3,489,267 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
UNIVERSITY OF PITTSBURGH THE | $850,000 | Trans-NIH Recovery Act Research Support This research proposal addresses the topic of how to clinically evaluate cell therapies which are being investigated for a variety of cardiovascular applications. Congestive heart failure resulting from myocardial infarction and subsequent adverse left | National Institutes of Health | 9/23/2009 |
UNIVERSITY OF PITTSBURGH THE | $847,830 |
Trans-NIH Recovery Act Research Support Novel Approaches to Screening for Inflicted Childhood Neurotrauma Inflicted childhood neurotrauma (ICN) - traumatic brain injury due to child abuse - is the leading cause of death from traumatic brain injury (TBI) in children less than 2 yrs of age. Rec
This spending item is part of a $1,151,244 allocation.
See details
|
National Institutes of Health | 9/22/2009 |
ALLEGHENY INTERMEDIATE UNIT 3 FOUNDATION | $835,101 | ARRA - Head Start Head Start 2009 ARRA COLA Quality Improvement funding will be used to increase Head Start Salaries and Fringe Benefits for 226 staff over a 12 month period and will be given in the form of a stipend in addition to their regular salaries. We will also imp | Administration for Children and Families | 5/28/2009 |
BOARD OF PUBLIC EDUCATION SCHOOL DISTRICT OF PITTSBURGH (INC) | $816,306 | ARRA - Head Start Award Description: Head Start 2009 ARRA COLA Quality Improvement Funding, Allegheny County, full day (6 hour) program, purpose of Head Start is to provide early childhood education to low-income children ages 3-5. | Administration for Children and Families | 6/12/2009 |
ALLEGHENY-SINGER RESEARCH INSTITUTE | $814,998 |
Trans-NIH Recovery Act Research Support Streptococcus pneumoniae has remained one of the major causative agents of potentially life threatening human disease in our era. Nevertheless, introduction of antibiotics (penicillin) and - more recently - the conjugate vaccine provoked major evolutionar
This spending item is part of a $1,278,754 allocation.
See details
|
National Institutes of Health | 7/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $803,302 |
Trans-NIH Recovery Act Research Support Pulmonary embolism (PE) affects many, with an estimated incidence of up to 69 cases per 100,000 persons annually. In the U.S., 101,000 patients were hospitalized with a primary diagnosis of PE in 2002, resulting in direct medical costs of $720 million. Ou
This spending item is part of a $1,104,458 allocation.
See details
|
National Institutes of Health | 8/07/2009 |
Young Women's Christian Association of Greater Pittsburgh | $800,612 |
ARRA Child Care and Development Block Grant The American Recovery and Reinvestment Act (ARRA) Child Care and Development Fund (CCDF) funds have two mandatory earmarks, Infant/Toddler and Quality. The Infant/Toddler funds are utilized for new center-based Keystone Babies programs. Specifically, th
This spending item is part of a $60,146,767 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
Mon Valley Education Consortium | $800,254 |
ARRA - Early Head Start The University of Pittsburgh Office of Child Development will provide Early Head Start services to families with infant and toddlers. The model is primarily home-based with children within Allegheny County. The primary communities are the city of Clairton
This spending item is part of a $2,639,588 allocation.
See details
|
Administration for Children and Families | 11/19/2009 |
SQUIRREL HILL HEALTH CENTER | $792,700 | ARRA Health Center Integrated Services Development Initiative[g1] Grant Name: Facility Investment Program Grant Purpose: Funds were awarded for capital and equipment costs of renovating and equipping leasehold site for new oral health center. Goals: To construct a new fully equipped oral health cecenter that will creat... Show more | Health Resources and Services Administration | 10/29/2009 |
MAGEE-WOMENS HEALTH CORPORATION | $783,687 | Trans-NIH Recovery Act Research Support We are interested in understanding transcriptional regulation during early oogenesis, specifically the post-mitotic stages, and the transition from prenatal to postnatal ovary, when clusters of oocytes begin to form into primordial follicles. Early stages | National Institutes of Health | 9/22/2009 |
UNIVERSITY OF PITTSBURGH THE | $757,500 | Trans-NIH Recovery Act Research Support Global and regional epigenetic changes, including CpG dinucleotide methylation and de-methylation, in response to environmental cues, have been implicated in a growing number of human diseases including various cancers, rheumatic and autoimmune diseases, | National Institutes of Health | 6/01/2009 |
UNIVERSITY OF PITTSBURGH THE | $757,500 | Trans-NIH Recovery Act Research Support Irradiation Damage and Protection of Pulmonary Endothelium Oxidative Lipidomics Radiation exposure leads to the development of severe acute inflammatory response and late damage to the lung culminating in delayed fibrosis. Pulmonary endothelium is the loc | National Institutes of Health | 8/31/2009 |
UNIVERSITY OF PITTSBURGH THE | $757,500 | Trans-NIH Recovery Act Research Support Specific Aim: Examine cellular energetics and maintenance of the mitochondrial membrane potential (MMP) in ATP61 mutants. A. Examine energetics as a function of age in ATP61 mutants and controls. Young ATP61 mutants did NOT exhibit an energetic defect | National Institutes of Health | 9/04/2009 |
UNIVERSITY OF PITTSBURGH THE | $757,500 | Trans-NIH Recovery Act Research Support A major mechanism for regulating the activity of biogenic amine neurotransmitter transporters, the important targets for therapeutic antidepressants and psychostimulant drugs of abuse, is through modulation of the abundance of functional transporters at t | National Institutes of Health | 7/16/2009 |
UNIVERSITY OF PITTSBURGH THE | $757,500 | Trans-NIH Recovery Act Research Support It is now established that at least three unique cell death pathways contribute to neuronal death after traumatic brain injury (TBI) in experimental models and in humans. These include the necrotic, caspase-dependent apoptotic, and caspase-independent apo | National Institutes of Health | 7/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $753,061 |
Trans-NIH Recovery Act Research Support General Challenge Area 15: Translational Science. Challenge Topic 15-ES-101: Effects of Environmental Exposures on Phenotypic Outcomes Using Non-Human Models. Monogenic forms of Parkinson disease (PD) are uncommon, accounting for about 10% of all cases
This spending item is part of a $999,999 allocation.
See details
|
National Institutes of Health | 9/21/2009 |
UNIVERSITY OF PITTSBURGH THE | $748,546 | Trans-NIH Recovery Act Research Support The award concerns the discovery and development of novel therapeutic agents that target HIV-1 ribonucleaseH (RNH) and bifunctional agents that target both HIV-1 reverse transcriptase DNA polymerase activity and RT-associated RNH activity. The overall hyp | National Institutes of Health | 5/29/2009 |
UNIVERSITY OF PITTSBURGH THE | $738,154 | Trans-NIH Recovery Act Research Support This was originally a 5-year grant proposal (competing renewal) to determine whether a renal extracellular 2',3'-cAMP-adenosine pathway exists, whether it is mediated by ecto-enzymes that are different from those mediating the 3',5'-cAMP-adenosine pathway | National Institutes of Health | 7/20/2009 |
UNIVERSITY OF PITTSBURGH THE | $723,556 | Trans-NIH Recovery Act Research Support Regenerative medicine approaches for the reconstitution of missing or injured tissues and organs involves the use of scaffolds, cells, and bioactive molecules. The use of biologic scaffolds seeded with cells is a common approach and several applications | National Institutes of Health | 5/14/2009 |
STEELWORKERS CHARITABLE & EDUCATIONAL ORGANIZATION | $720,250 | Trans-NIH Recovery Act Research Support The Steelworkers Charitable and Educational Organization's (SCEO) Tony Mazzocchi Center (TMC), which is a joint project of the United Steelworkers (USW) and the Labor Institute, received $720,250 in supplemental training funds from the National Institute | National Institutes of Health | 9/06/2009 |
UNIVERSITY OF PITTSBURGH THE | $712,819 |
Trans-NIH Recovery Act Research Support Chronic lung diseases represent a broad spectrum of chronic fibrosing/inflammatory lung conditions that are for the most part poorly responsive to treatment and often fatal. COPD/emphysema is the fourth leading cause of death in the United States and the
This spending item is part of a $1,654,805 allocation.
See details
|
National Institutes of Health | 11/04/2011 |
UNIVERSITY OF PITTSBURGH THE | $693,518 |
Trans-NIH Recovery Act Research Support This project addresses broad Challenge Area: Enabling Technologies, Challenge Topic 06-HD-101, Improved Interfaces for Prostheses to Impact Rehabilitation Outcomes. Recent advances in decoding motor intentions and the technology to record populations o
This spending item is part of a $1,000,000 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
UNIVERSITY OF PITTSBURGH THE | $681,294 |
Trans-NIH Recovery Act Research Support This research project seeks to improve understanding of the connection of bone marrow fat (BMF) with bone density, geometry and turnover by recruiting 150 men who are currently participating in the Osteoporotic Fractures in Men (MrOS) study at the Pittsbu
This spending item is part of a $857,596 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
UNIVERSITY OF PITTSBURGH THE | $677,678 | Trans-NIH Recovery Act Research Support Nongenomic Androgen Signaling in Sertoli Cells. The long-term goal of this project remains to determine the molecular and cellular mechanisms by which testosterone regulates spermatogenesis. Aim 1 is to determine whether non-classical signaling by testost | National Institutes of Health | 7/29/2009 |
UNIVERSITY OF PITTSBURGH THE | $676,967 |
Trans-NIH Recovery Act Research Support Stroke is the leading cause of serious long-term disability in the United States. Adults who have strokes in the right side of the brain often 'miss the point' of what they hear, read, or see -- a life-altering problem that can have devastating effects o
This spending item is part of a $754,665 allocation.
See details
|
National Institutes of Health | 9/02/2009 |
UNIVERSITY OF PITTSBURGH THE | $671,712 |
Trans-NIH Recovery Act Research Support Overall Goal:-Obtain maximum molecular information by Mass Spectrometry from a single 10 micron diameter cell. Ionwerks has created new classes of nanoparticulate (NP) matrices which can be localized in submonolayer amounts on or within the first several
This spending item is part of a $2,996,567 allocation.
See details
|
National Institutes of Health | 8/23/2010 |
UNIVERSITY OF PITTSBURGH THE | $657,790 | Trans-NIH Recovery Act Research Support Stress is a major factor in the onset and relapse to drug abuse. Over the past funding period, the effects of stress on the amygdala-locus coeruleus (LC) system, and how the response is altered after chronic stress exposure, was examined. In this resubmi | National Institutes of Health | 7/16/2009 |
CARNEGIE MELLON UNIVERSITY | $646,053 |
ARRA - Strategic Health IT Advanced Research Projects (SHARP) The Strategic Healthcare IT Advanced Research Projects on Security (SHARPS) project will advance the sophistication, development, and deployment of security and privacy for Health Information Technology (HIT) through long-term research thahat is strategical... Show more
This spending item is part of a $15,000,000 allocation.
See details
|
Health and Human Services, Department of | 3/19/2010 |
UNIVERSITY OF PITTSBURGH THE | $644,952 | Recovery Act Comparative Effectiveness Research - AHRQ The University of Pittsburgh Postdoctoral Program in Comparative Effectiveness Research provides a 2-year training experience in comparative effectiveness research for motivated, creative individuals with prior health professional or research dodoctorates.... Show more | Agency for Healthcare Research and Quality | 7/01/2010 |
COMMUNITY COLLEGE OF ALLEGHENY COUNTY | $640,996 |
ARRA - Health Information Technology Professionals in Health Care Tidewater Community College, in collaboration with an active consortium of 22 community colleges, will facilitate the adoption and meaningful use of electronic health records (EHRs) among primary health care providers in the twelve statates of the mid Atlan... Show more
This spending item is part of a $16,267,603 allocation.
See details
|
Health and Human Services, Department of | 4/02/2010 |
Turtle Creek Valley Mental Health/Mental Retardation, Inc. | $640,068 |
ARRA - Early Head Start The University of Pittsburgh Office of Child Development will provide Early Head Start services to families with infant and toddlers. The model is primarily home-based with children within Allegheny County. The primary communities are the city of Clairton
This spending item is part of a $2,639,588 allocation.
See details
|
Administration for Children and Families | 11/19/2009 |
UNIVERSITY OF PITTSBURGH THE | $631,756 | Trans-NIH Recovery Act Research Support There are many obstacles to cure of HIV-1 infection especially inadequate knowledge of the reservoirs of HIV-1 persistence. The co-existence of lymphoma requiring treatment in some patients with HIV-1 offers the opportunity to study the impact of cytoabla | National Institutes of Health | 9/11/2009 |
UNIVERSITY OF PITTSBURGH THE | $627,830 | Trans-NIH Recovery Act Research Support Ready access to seven-membered rings systems will facilitate the synthesis of biologically important compounds possessing this ring system. Three carbocyclic cores of three targets, thapsigargin, grayanotoxin III and guanacastepene J, will be synthesiz | National Institutes of Health | 9/30/2009 |
Young Women's Christian Association of Greater Pittsburgh | $624,292 |
ARRA Child Care and Development Block Grant The American Recovery and Reinvestment Act (ARRA) Child Care and Development Fund (CCDF) funds have two mandatory earmarks, Infant/Toddler and Quality. The Infant/Toddler funds are utilized for new center-based Keystone Babies programs. Specifically, th
This spending item is part of a $60,146,767 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
UNIVERSITY OF PITTSBURGH THE | $623,500 | Trans-NIH Recovery Act Research Support Cross-regulation of apoptosis and autophagy as a molecular basis for reversal of tumor TRAIL resistance. Defects in apoptotic capability that evolve during tumorigenesis promote tumor growth, provide survival advantage, and confound treatment. Such defec | National Institutes of Health | 5/05/2009 |
UNIVERSITY OF PITTSBURGH THE | $618,969 |
Trans-NIH Recovery Act Research Support We convene our investigators, sub-contractors and staff for weekly meetings focused on data quality, analysis and curriculum development.. Project staff and PIs have additional weekly meetings. ICF Macro is nearing completion of in-depth interviews and te
This spending item is part of a $2,355,935 allocation.
See details
|
National Institutes of Health | 9/27/2010 |
UNIVERSITY OF PITTSBURGH THE | $616,867 | Trans-NIH Recovery Act Research Support Title: FMRI Examination of Working Memory after TBI Each year, over 230,000 people survive moderate and severe traumatic brain injury (TBI). As a result, a large number of individuals with TBI endure life-long impairment and disability. Memory disturba | National Institutes of Health | 7/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $605,905 | ARRA Grants for Training in Primary Care Medicine and Dentistry Training and Enhancement This is an award through the Health Services And Research Administration to provide the country with trained primary care physician faculty and researchers who will 1) will prepare our future workforce of primaryry care physicians to provide care to the und... Show more | Health Resources and Services Administration | 7/15/2010 |
UNIVERSITY OF PITTSBURGH THE | $599,506 | Trans-NIH Recovery Act Research Support Our goal is to improve our curriculum in clinical and translational science (CTS) by developing a competency-based educational structure across our CTS coursework. While our training is rigorous and our on-going evaluations of educational outcomes have | National Institutes of Health | 9/03/2009 |
Young Women's Christian Association of Greater Pittsburgh | $593,879 |
ARRA Child Care and Development Block Grant The American Recovery and Reinvestment Act (ARRA) Child Care and Development Fund (CCDF) funds have two mandatory earmarks, Infant/Toddler and Quality. The Infant/Toddler funds are utilized for new center-based Keystone Babies programs. Specifically, th
This spending item is part of a $60,146,767 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
CARNEGIE MELLON UNIVERSITY | $592,971 | Trans-NIH Recovery Act Research Support This award supports scientific research into cancer development and progression. The goal of the project is to develop computational methods for determining how cancerous cells within tumors accumulate genetic damage over time, causing them to become inc | National Institutes of Health | 5/11/2009 |
UNIVERSITY OF PITTSBURGH THE | $591,184 | Trans-NIH Recovery Act Research Support Multi-Center AIDS Cohort Study: Genetic Correlates of Dyslipedmia and Cardiovascular Disease in the MACS. This project is an investigation of the genetic causes of some of the most severe side-effects of anti-retroviral therapy experienced by many HIV-p | National Institutes of Health | 9/21/2009 |
CARNEGIE MELLON UNIVERSITY | $585,345 |
Trans-NIH Recovery Act Research Support In this proposal, we used advanced magnetic resonance imaging (MRI) technology to visualize the trafficking of cellular immunotherapy against colorectal cancer. Most often applied to advanced cancer, where existing therapies have limited efficacy, cellul
This spending item is part of a $976,850 allocation.
See details
|
National Institutes of Health | 5/05/2009 |
UNIVERSITY OF PITTSBURGH THE | $585,072 |
Trans-NIH Recovery Act Research Support Several studies of adults with chronic liver disease have suggested that neuropsychological abnormalities associated with both obvious and sub-clinical hepatic encephalopathy may not fully reverse following liver transplantation with the dominant abnormal
This spending item is part of a $834,478 allocation.
See details
|
National Institutes of Health | 6/14/2010 |
UNIVERSITY OF PITTSBURGH THE | $576,199 |
The Multimodal Treatment Study of Children with ADHD (MTA) is a multi-center longitudinal follow up study of children treated for ADHD. The MTA study initially enrolled 579 children with ADHD at ages 7 to 9, at seven sites, for a randomized trial comparin
This spending item is part of a $653,694 allocation.
See details
|
National Institutes of Health | 4/22/2010 |
UNIVERSITY OF PITTSBURGH THE | $566,130 |
Trans-NIH Recovery Act Research Support Regenerative medicine approaches for the reconstitution of missing or injured tissues and organs involves the use of scaffolds, cells, and bioactive molecules. The use of biologic scaffolds seeded with cells is a common approach and several applications
This spending item is part of a $956,840 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
UNIVERSITY OF PITTSBURGH THE | $565,851 | Trans-NIH Recovery Act Research Support We previously discovered that a protein called CYP24 is over-produced in lung cancer. The purpose of this award is to determine the role of CYP24 in stimulating the development and/or growth of lung tumors. CYP24 degrades the natural anti-tumor agent, 1,2 | National Institutes of Health | 5/21/2009 |
UNIVERSITY OF PITTSBURGH THE | $565,187 | The University of Pittsburgh has been awarded a contract to provide tumor types to the NCI for The Cancer Genome Atlas (TCGA) project. Specifically this award is to fund the provision of Lung squamous cell carcinoma (50 cases), Lung adenocarcinoma (30 ca | National Institutes of Health | 3/22/2010 |
EAST LIBERTY FAMILY HEALTH CARE CENTER | $547,500 | ARRA Health Center Integrated Services Development Initiative[g1] ARRA - CAPITAL IMPROVEMENT PROGRAM. Project 1- to add 500 sq. foot annex to E. Liberty office, adding 1 exam room, 2 counseling rooms and 6 additonal work spaces, as well as reconfiguring front desk area to be able to serve more patieients. Project #2- ren... Show more | Health Resources and Services Administration | 6/25/2009 |
UNIVERSITY OF PITTSBURGH THE | $537,076 | Trans-NIH Recovery Act Research Support Cancer of the colon and rectum (colorectal cancer, CRC) is the third leading site of cancer in the United States and the most common form of gastrointestinal malignancy. CRC accounts for approximately 150,000 new cases annually, and 6,000 of these are tre | National Institutes of Health | 7/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $536,687 | Trans-NIH Recovery Act Research Support It is estimated that over 500,000 persons across the world will die this year from hepatocellular carcinoma (HCC). HCC is a major health problem, particularly in underdeveloped countries, and poses a series of complex health management issues. Elucidati | National Institutes of Health | 6/04/2009 |
UNIVERSITY OF PITTSBURGH THE | $526,615 | Trans-NIH Recovery Act Research Support Research the pathogenesis of the lysosomal storage disease mucolipidosis type IV (MLIV) is why dysregulation of the ion channel TRPML1 lead to buildup of storage bodies. Finding whether TRPML1 directly regulates membrane traffic or lysosomal lipid hydroly | National Institutes of Health | 9/18/2009 |
UNIVERSITY OF PITTSBURGH THE | $524,960 |
Trans-NIH Recovery Act Research Support The goal of this proposal is to perform the integrated multi-disciplinary large animal studies needed to advance clinical treatment and assessment of articular cartilage injury and degeneration in the United States. Microfracture, a simple and minimally i
This spending item is part of a $1,730,845 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
UNIVERSITY OF PITTSBURGH THE | $523,511 |
Trans-NIH Recovery Act Research Support DESCRIPTION (provided by applicant): This project applies genomic and high-throughput genetic strategies to the global health emergency of tuberculosis. It creates new resources that will bridge clinic and laboratory, and quicken research for new, cheaper
This spending item is part of a $3,994,132 allocation.
See details
|
National Institutes of Health | 9/29/2010 |
UNIVERSITY OF PITTSBURGH THE | $522,056 |
Trans-NIH Recovery Act Research Support Intravenous (IV) administration of tissue plasminogen activator (tPA) is an effective and approved therapy for acute stroke when treatment is begun within 3 hours of symptom onset. Recent data suggest limited benefits up to 4.5 hours after symptom onset
This spending item is part of a $3,067,107 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
UNIVERSITY OF PITTSBURGH THE | $521,238 |
Trans-NIH Recovery Act Research Support A novel paradigm has been developed in rural Appalachia within West Virginia and shown that trained adolescents interested in science can with guidance conduct Community Based Participatory Research (CBPR). The Community Appalachian Investigation and Res
This spending item is part of a $1,000,000 allocation.
See details
|
National Institutes of Health | 9/09/2010 |
CARNEGIE MELLON UNIVERSITY | $510,300 | Trans-NIH Recovery Act Research Support Information on subcellular location is critical to determining the function of unknown proteins, and high-resolution knowledge of locations for entire proteomes will be essential for systems biology approaches to copmprehensive modeling of cell behavior. | National Institutes of Health | 9/28/2009 |
UNIVERSITY OF PITTSBURGH THE | $505,786 |
Recovery Act Comparative Effectiveness Research - AHRQ Bipolar is a severe and lifelong illness affecting 4.5% of the population ? about 14 million people in the U.S. It is one of the top 10 most disabling medical conditions worldwide according to the World Health Organization. Traditionally, the mooood stabili... Show more
This spending item is part of a $9,784,863 allocation.
See details
|
Agency for Healthcare Research and Quality | 9/28/2010 |
UNIVERSITY OF PITTSBURGH THE | $501,581 |
Trans-NIH Recovery Act Research Support Red blood cell transfusions are extremely common medical interventions with more than 11 million red blood cell units transfused in the United States and 75 million worldwide. Yet, it remains unclear when patients should receive red blood cell transfusion
This spending item is part of a $2,605,144 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
UNIVERSITY OF PITTSBURGH THE | $501,383 |
Trans-NIH Recovery Act Research Support Mechanisms for Arsenic-Induced Vascular Disease In response to NOT-OD-09-058: NIH Announces the Availability of Recovery Act for Competitive Revision Applications; this is an application for a competitive revision to expand scope of the aims for 5R01-ES0
This spending item is part of a $741,303 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
UNIVERSITY OF PITTSBURGH THE | $501,237 | Trans-NIH Recovery Act Research Support Schizophrenia is a common, devastating illness that can not be treated adequately. Hence it is important to understand its causation. Schizophrenia is heritable, providing an important clue about its origins. Ongoing studies show that variation in DNA | National Institutes of Health | 9/30/2009 |
UNIVERSITY OF PITTSBURGH THE | $498,000 | Trans-NIH Recovery Act Research Support The objective of this proposal is to acquire a high-resolution ultrasound imaging system for use in biomedical research using small animals spanning the size of mice embryos to rabbits. This first and only commercially available high-frequency, high-resol | National Institutes of Health | 1/07/2010 |
UNIVERSITY OF PITTSBURGH THE | $496,719 | Trans-NIH Recovery Act Research Support The 9.4-T MR instrument has been crucial to successfully carry out our NIH-funded projects. Maintaining the 9.4-T instrument with the requested console upgrade as state-of-the-art equipment will be important to continuously perform proposed studies. The | National Institutes of Health | 1/28/2010 |
UNIVERSITY OF PITTSBURGH THE | $485,889 | Trans-NIH Recovery Act Research Support This application was written in response to the NIH Announcement for the Availability of Recovery Act Funds for Competitive Revision Applications (NOT-OD-09-058). The experiments outlined in this application were designed to expand the scope of the specif | National Institutes of Health | 9/25/2009 |
UNIVERSITY OF PITTSBURGH THE | $481,354 |
Trans-NIH Recovery Act Research Support Paget's disease (PD) is the second most common bone disease and affects 1-2 million patients in the U.S. This competitive revision will test the hypothesis that both an environmental factor [measles virus nucleocapsid protein (MVNP)] and a genetic factor
This spending item is part of a $610,272 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
DUQUESNE UNIVERSITY OF THE HOLY SPIRIT | $470,707 |
Trans-NIH Recovery Act Research Support A scientific search for therapeutically useful compounds in combating psychostimulant abuse and addiction has been in progress for decades, with no clinically available agents to date. Rational, brain receptor protein-guided design of novel antidepressant
This spending item is part of a $627,250 allocation.
See details
|
National Institutes of Health | 6/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $464,323 |
ARRA - Prevention and Wellness--State Territories and Pacific Islands This grant supports promotion of wellness and chronic disease prevention through state-wide and local policy environment and environmental change. Specific areas that are addressed through this grant are obesity, physical activitity, nutrition and tobacco ... Show more
This spending item is part of a $1,544,828 allocation.
See details
|
Centers for Disease Control and Prevention | 2/06/2010 |
UNIVERSITY OF PITTSBURGH THE | $463,521 | Trans-NIH Recovery Act Research Support This award funds a newly available CereTom CT scanner and related accessories which allow it to be combined with a preclinical non-human primate microPET P4 scanner in the fashion of hybrid PET/CT systems, giving a true hybrid imaging platform geared spec | National Institutes of Health | 4/28/2009 |
UNIVERSITY OF PITTSBURGH THE | $460,440 | Trans-NIH Recovery Act Research Support This is a supplemental project to the Conte Center for the Neuroscience of Mental Disorders (CCNMD), Inhibition, Oscillations and Information Processing in Schizophrenia, which aims to identify critical molecular abnormalities in GABA neurotransmission, e | National Institutes of Health | 5/18/2010 |
UNIVERSITY OF PITTSBURGH THE | $455,136 | Trans-NIH Recovery Act Research Support The award issued under the American Recovery and Reinvestment for the period 9/30/09-9/29/11 is a supplement to current grant entitled 'Biostatistical Center for the NSABP'. The National Surgical Adjuvant Breast and Bowel Project (NSABP) is a clinical tr | National Institutes of Health | 9/18/2009 |
UNIVERSITY OF PITTSBURGH THE | $451,155 | Trans-NIH Recovery Act Research Support Using a longitudinal design we will examine two objectives. Objective 1 is to determine the impact of the Medicare Part D drug benefit intervention on racial differences in the use of lipid lowering medications in those with IHD (i.e., a history of MI | National Institutes of Health | 9/04/2009 |
DUQUESNE UNIVERSITY OF THE HOLY SPIRIT | $451,056 |
Trans-NIH Recovery Act Research Support Molecularly targeted agents against receptor tyrosine kinases (RTK), particularly the antiangiogenic agents (AAs), have caused a paradigm shift in cancer chemotherapy. These agents target tumor angiogenic mechanisms (sprouting of new blood vessels) that a
This spending item is part of a $611,564 allocation.
See details
|
National Institutes of Health | 5/28/2009 |
STO-ROX NEIGHBORHOOD HEALTH COUNCIL INC | $442,675 | ARRA Health Center Integrated Services Development Initiative[g1] The purpose of the Capital Improvement Grant was two fold: first, to replace or purchase some much needed equipment and secondly to purchse the equipment to ready us for EHRs. Goals: (1)to replace two air conditioning units on the roooof of the Health Cent... Show more | Health Resources and Services Administration | 6/25/2009 |
UNIVERSITY OF PITTSBURGH THE | $441,615 | Trans-NIH Recovery Act Research Support Aim 1: To test the hypothesis that a-Syn inhibits TH in vivo by effects on PP2A. Our in vitro data suggest that a-Syn inhibits TH and reduces DA synthesis, by increasing PP2A activity. To assess this in vivo, we will use nigral and striatal tissue from | National Institutes of Health | 7/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $439,048 | Trans-NIH Recovery Act Research Support This application addresses Notice Number (NOT-OD-09-058) and Notice Title: NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications, and asks for competitive revision of R01DK78755. The acyl-CoA dehydrogenases (ACDs) are | National Institutes of Health | 9/16/2009 |
UNIVERSITY OF PITTSBURGH THE | $435,756 |
Trans-NIH Recovery Act Research Support This application addresses broad Challenge Area (08) Genomics and Specific Challenge Topic, 08-HL-101* 'Identify causal genetic variants associated with heart, lung, and blood diseases by application of targeted DNA capture and massively parallel sequenci
This spending item is part of a $1,000,000 allocation.
See details
|
National Institutes of Health | 9/18/2009 |
UNIVERSITY OF PITTSBURGH THE | $433,933 | Trans-NIH Recovery Act Research Support Current trends in health care suggest that the majority of older individuals will obtain their health care solely from their family physician; however, many elderly do not report memory loss and, among those that do, few are referred for specialist evalua | National Institutes of Health | 9/24/2010 |
CARNEGIE MELLON UNIVERSITY | $432,760 | Trans-NIH Recovery Act Research Support This awards supports the purchase of an Andor Revolution XD Spinning Disk Confocal System on a Nikon Perfect Focus TIRF Microscope. The acquisition of this instrument will provide on-site access to state of the art high-speed multi-color confocal and TIR | National Institutes of Health | 4/29/2010 |
UNIVERSITY OF PITTSBURGH THE | $429,079 | Trans-NIH Recovery Act Research Support This award will enable the purchase of a ThermoElectron TSQ Vantage integrated with the Eksigent Ultra 1D Plus NanoLC and Autosampler to make targeted proteomic measurements for the projects of a group of ten NIH-funded faculty investigators from the INIA | National Institutes of Health | 9/07/2010 |
UNIVERSITY OF PITTSBURGH THE | $422,346 |
Trans-NIH Recovery Act Research Support Funding for this protocol is to allow enrollment of an additional group of patients who have malignancies that are positive for BRCA mutations. Specific Aims This protocol will evaluate the combination chemotherapy regimen of the PARP inhibitor ABT-888 in
This spending item is part of a $699,574 allocation.
See details
|
National Institutes of Health | 7/17/2009 |
CARNEGIE MELLON UNIVERSITY | $422,125 | Trans-NIH Recovery Act Research Support The project long-term goal was to support the development of anti-infective drugs. The focus is Candida albicans, the major invasive fungal pathogen of humans, which causes lethal deep tissue infections and sever mucosal infections. This project will im | National Institutes of Health | 6/17/2009 |
RAND CORPORATION, THE | $420,678 | Trans-NIH Recovery Act Research Support DESCRIPTION (provided by applicant): There is ample evidence to suggest that a relationship exists between exposure to cigarette advertising and smoking in children and adolescents under the age of 18. Studies documenting this relationship have been extre | National Institutes of Health | 5/13/2009 |
UNIVERSITY OF PITTSBURGH THE | $416,625 | Trans-NIH Recovery Act Research Support Depression is a leading cause of disability worldwide. Yet, despite the discovery of clinically-effective antidepressants over fifty years ago, the biological mechanisms of the illness remain mostly uncharacterized. As a result, very few new drugs are dev | National Institutes of Health | 5/14/2009 |
UNIVERSITY OF PITTSBURGH THE | $416,625 | Trans-NIH Recovery Act Research Support These studies are focused on the molecular structures of protein complexes that form between the HIV virulence factor Nef and host cell signaling proteins (Src-family kinases) in HIV-infected cells. Formation of these complexes is important to AIDS progr | National Institutes of Health | 5/29/2009 |
UNIVERSITY OF PITTSBURGH THE | $416,625 | Trans-NIH Recovery Act Research Support Tuberculosis(TB), caused by the organism M.tuberculosis (Mtb), kills more than 2 million people worldwide every year(1). Our limited understanding of how vaccine responses mediates protection in the lung remains a major hurdle to successful vaccine desig | National Institutes of Health | 7/22/2009 |
UNIVERSITY OF PITTSBURGH THE | $416,625 | Trans-NIH Recovery Act Research Support Obesity has become the most common nutritional disorder in the developed world and the co-morbidities of obesity contribute significantly to mortality and medical costs throughout the world. Biological or circadian rhythms have profound effects on energy | National Institutes of Health | 6/22/2009 |
UNIVERSITY OF PITTSBURGH THE | $416,625 | Trans-NIH Recovery Act Research Support This application investigates whether increases in low-level HIV-1 residual viremia (HIV-1 RNA) set point in patients receiving antiretroviral therapy can serve as an early indicator of impending virologic failure and whether these increases in HIV-1 resi | National Institutes of Health | 6/04/2009 |
UNIVERSITY OF PITTSBURGH THE | $416,625 | Trans-NIH Recovery Act Research Support Cyloxygenase-2 (COX-2), the enzyme responsible for production of prostaglandins, has been identified as an important contributor to brain damage following hypoxia-ischemia. Unfortunately, COX-2 inhibitors have been reported to cause cerebral and cardiac t | National Institutes of Health | 6/02/2009 |
UNIVERSITY OF PITTSBURGH THE | $416,625 | Trans-NIH Recovery Act Research Support Bacillus anthracis is an important human pathogen that is the etiological agent of anthrax in humans and a potential biological weapon. Two large plasmids, pXO1 and pXO2, play a major role in the virulence of this organism. Gene transfer can frequently o | National Institutes of Health | 5/14/2009 |
UNIVERSITY OF PITTSBURGH THE | $416,625 | Trans-NIH Recovery Act Research Support Chlamydia trachomatis infections are the leading cause of involuntary infertility and ectopic pregnancy in women. Although antibiotic treatment cures infection, it does not ameliorate the inflammatory process that leads to the development of disease. We | National Institutes of Health | 7/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $415,530 | Trans-NIH Recovery Act Research Support This application is for an administrative supplement to the Pittsburgh component of the Multicenter AIDS Cohort Study (MACS) Cooperative Agreement (1U01-AI-35041). In it, we propose to evaluate the role of apoptosis and autophagy in T cell depletion and d | National Institutes of Health | 9/27/2010 |
UNIVERSITY OF PITTSBURGH THE | $413,535 | Trans-NIH Recovery Act Research Support This study is aimed to elucidate the significant effect and the mechanisms of RNA editing enzyme ADAR1 (Adenosine Deaminase Acting on RNA -1). ADAR1 is an essential protein required for cell survival and embryonic development. Knockout of the gene en | National Institutes of Health | 6/04/2009 |
UNIVERSITY OF PITTSBURGH THE | $412,013 |
Trans-NIH Recovery Act Research Support Funding for this protocol is to allow enrollment of an additional group of patients who have malignancies that are positive for BRCA mutations. Specific Aims: This protocol will evaluate the combination chemotherapy regimen of the PARP inhibitor ABT-888
This spending item is part of a $749,856 allocation.
See details
|
National Institutes of Health | 7/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $411,731 | Trans-NIH Recovery Act Research Support Advances in medical monitoring have failed to improve outcomes and significantly impact medical decision making by bedside clinicians, particularly in the acute care setting. Computerized decision support technologies based on quantitative, mechanistic m | National Institutes of Health | 7/22/2009 |
UNIVERSITY OF PITTSBURGH THE | $409,026 | Trans-NIH Recovery Act Research Support This is a pilot study to establish a profile of oxidative stress among participants in the Epidemiology of Diabetes Complications (EDC) study to assess whether the degree to which an individual is able to respond to oxidative stress modifies the risk of d | National Institutes of Health | 8/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $406,323 | Trans-NIH Recovery Act Research Support The objective of the award is to develop four SPNW sensors for four cardiac markers (myoglobin, BNP, c-TnI, and CK-MB) for rapid and accurate AMI diagnosis and prognosis. In order to accomplish the objective, our specific aims include: (a) develop an eff | National Institutes of Health | 4/30/2009 |
UNIVERSITY OF PITTSBURGH THE | $405,889 | Trans-NIH Recovery Act Research Support Confocal microscopy using spinning disk or moving pinhole array microscopes has facilitated the adoption of optical sectioning methods as a primary tool for imaging living cells. This award will place an automated high speed widefield/confocal instrument | National Institutes of Health | 7/01/2010 |
UNIVERSITY OF PITTSBURGH THE | $398,874 | Trans-NIH Recovery Act Research Support The overall goals of this research are to improve clinical decision making in Pediatric Acute Liver Failure (PALF) by (1) developing quantitative models of prognosis and disease progression, and (2) using them to calibrate optimization models of the trans | National Institutes of Health | 6/10/2009 |
UNIVERSITY OF PITTSBURGH THE | $398,499 | Trans-NIH Recovery Act Research Support The overall purpose of the award is to understand hepatitis C virus (HCV) life cycle and the HCV-associated steatosis with implications for the development of novel antiviral therapeutics. HCV infection can cause many liver diseases including acute and c | National Institutes of Health | 5/29/2009 |
Young Women's Christian Association of Greater Pittsburgh | $397,271 |
ARRA Child Care and Development Block Grant The American Recovery and Reinvestment Act (ARRA) Child Care and Development Fund (CCDF) funds have two mandatory earmarks, Infant/Toddler and Quality. The Infant/Toddler funds are utilized for new center-based Keystone Babies programs. Specifically, th
This spending item is part of a $60,146,767 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
UNIVERSITY OF PITTSBURGH THE | $393,965 | Trans-NIH Recovery Act Research Support Lanthanide Containing ZnS Nanoparticles The overall objective of the research is to develop a novel family of luminescent nanoparticles that emit visible or near infrared light and are specifically designed to operate as fluorescent reporters in a broad | National Institutes of Health | 5/05/2009 |
UNIVERSITY OF PITTSBURGH THE | $389,459 | Trans-NIH Recovery Act Research Support The ability of functional magnetic resonance imaging (fMRI) to detect brain function non-invasively with high spatial resolution opens great opportunities to advance our understanding of brain organization and function. Currently, most fMRI techniques are | National Institutes of Health | 4/29/2009 |
ALLEGHENY-SINGER RESEARCH INSTITUTE | $383,729 |
Trans-NIH Recovery Act Research Support This proposal addresses a problem central to the study of focal ischemic stroke therapy: the blood- brain barrier (BBB) breakdown via vasogenic edema that restricts the window of tPA administration. We will study the initial BBB disruption after which the
This spending item is part of a $415,950 allocation.
See details
|
National Institutes of Health | 6/15/2009 |
UNIVERSITY OF PITTSBURGH THE | $380,715 | RECOVERY-Computational Thinking to Support Clinicians and Biomedical Scientists | National Institutes of Health | 9/07/2010 |
ALLEGHENY-SINGER RESEARCH INSTITUTE | $380,028 |
Trans-NIH Recovery Act Research Support This Competitive Revision for 5R00DE018188-03 proposes to expand the parent project to include a non-viral method of gene delivery based upon ultrasound destruction of DNA-associated microbubbles. This ultrasound-assisted gene transfer (UAGT) works diffe
This spending item is part of a $434,047 allocation.
See details
|
National Institutes of Health | 9/23/2009 |
UNIVERSITY OF PITTSBURGH THE | $378,300 |
Trans-NIH Recovery Act Research Support Overall Purpose. Loss of mobility characterized by slowing gait speed, exertional fatigue and exhaustion is a hallmark of age-related functional decline. Current studies have not explained the biological reason for this slowing and loss of mobility. In pa
This spending item is part of a $855,594 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
UNIVERSITY OF PITTSBURGH THE | $377,111 |
Trans-NIH Recovery Act Research Support The objective of this funded study is to develop new scientific tools to investigate the relatedness of neural, biochemical, and vascular processes in the brain. This study will develop and advance neuroimaging techniques to simultaneously measure neuron
This spending item is part of a $411,765 allocation.
See details
|
National Institutes of Health | 6/05/2009 |
UNIVERSITY OF PITTSBURGH THE | $373,679 | Trans-NIH Recovery Act Research Support The newly awarded supplement to our project entitled Animal Model for SIV infection control is designated to support an additional project investigating the early events during mucosal SIVagm transmission in the African green monkey (AGM). The very early | National Institutes of Health | 9/23/2010 |
CARNEGIE MELLON UNIVERSITY | $372,287 | Trans-NIH Recovery Act Research Support The research supported by this award will lead to a new generation of bright fluorescence imaging agents for detecting and tracking single RNA molecules in living cells. This will be accomplished by covalently attaching fluorescent dyes to a nanostructure | National Institutes of Health | 9/28/2009 |
UNIVERSITY OF PITTSBURGH THE | $369,585 |
Trans-NIH Recovery Act Research Support Following the anthrax bioterror attacks in the US in 2001, awareness of the potentially devastating effects of attack with a bioweapon led to recognition of the need to take action and prepare against possible future nefarious events. F. tularensis was pl
This spending item is part of a $1,137,892 allocation.
See details
|
National Institutes of Health | 9/21/2009 |
COUNCIL OF 3 RIVERS AMERICAN INDIAN CENTER | $368,289 | ARRA - Head Start Project Title: 2009 American Recovery and Reinvestment Act Head Start/Early Head start COLA and Quality Improvement Funds. Project Description: This award provided ARRA Cost of Living Adjustment(COLA) and Quality Improvement funding consistent with the pr | Administration for Children and Families | 5/29/2009 |
UNIVERSITY OF PITTSBURGH THE | $366,632 | Trans-NIH Recovery Act Research Support This R21 award supports a 2 year project: Augmentation of NK cell-mediated anti-cancer activity by dietary BITC We have found that dietary benzyl-isothiocyanate (BITC) is able to augment host NK cell function. In this project, we will investigate the i | National Institutes of Health | 7/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $366,630 | Trans-NIH Recovery Act Research Support Prostate cancer, a leading cause of cancer related deaths among men in the United States, is usually diagnosed in the sixth or seventh decades of life, which allows a large window of opportunity for intervention to prevent or slow progression of the disea | National Institutes of Health | 7/16/2009 |
CARNEGIE MELLON UNIVERSITY | $363,774 | Trans-NIH Recovery Act Research Support This supplement is being used to support an additional full-time investigator, Dr. Alberto Gandini, who possesses particular skills and expertise not currently available in our group. The current team is comprised primarily of biomedical engineers, life s | National Institutes of Health | 8/01/2009 |
FISHER SCIENTIFIC COMPANY L.L.C. | $361,868 | Laboratory Equipment and Supplies. | National Institutes of Health | 9/20/2010 |
PRIMARY CARE HEALTH SERVICES INC | $355,893 | ARRA Health Center Integrated Services Development Initiative[g1] 1. Need- PCHS is in need of increased access to health services and continued care for the uninsured population. Additionally, HCH has identified a gap in service for homeless populations and would increase access through additional phphysician time at home... Show more | Health Resources and Services Administration | 3/27/2009 |
UNIVERSITY OF PITTSBURGH THE | $348,069 | Trans-NIH Recovery Act Research Support The proposed studies will test specific hypotheses about the mechanism and the role of Rho GTPases in the differential regulation of corneal epithelial cell cycle progression (proliferation) and corneal stromal cell activation that are critical in the nor | National Institutes of Health | 9/23/2009 |
CARNEGIE MELLON UNIVERSITY | $346,796 | Trans-NIH Recovery Act Research Support These funds are being used to develop a new approach to single molecule detection with improved brightness and flexibility. The studies are designed to establish the feasibility of this labeling strategy in single molecule analysis in living cells. This | National Institutes of Health | 9/30/2009 |
BOARD OF PUBLIC EDUCATION SCHOOL DISTRICT OF PITTSBURGH (INC) | $344,760 | ARRA - Head Start Award Description: The purpose of the Head Start ARRA Expansion award is to expand Head Start Services to 20 additional children in Pittsburgh, PA through the center based option. The Head Start program provides educational, health, and social services | Administration for Children and Families | 9/24/2009 |
UNIVERSITY OF PITTSBURGH THE | $341,954 | Trans-NIH Recovery Act Research Support High throughput assay development for Huntington's Disease - In this application we propose to develop new high throughput screening assays for identifying aggregation inhibitors in large libraries of small molecules. The premise of this proposal is that | National Institutes of Health | 5/05/2009 |
UNIVERSITY OF PITTSBURGH THE | $336,839 | Trans-NIH Recovery Act Research Support This is one-year bridge funding for the renewal of a study investigating if women with evidence of prior or current mycoplasma genitalium infection, measured by testing antibodies, are more likely to experience infertility, chronic pelvic pain, and recurr | National Institutes of Health | 9/13/2010 |
UNIVERSITY OF PITTSBURGH THE | $336,250 | Trans-NIH Recovery Act Research Support MDSCs will be isolated from Ercc1-/Delta mice and wt littermates (Ercc1+/ Delta) (at 1, 3, 5 and 7mths of age. We will also isolate MDSCs from the Ercc1-/- mice between 14 and 28 days of age. The hind limb muscles (gastrocnemius, soleus and tibialis anter | National Institutes of Health | 8/14/2009 |
UNIVERSITY OF PITTSBURGH THE | $333,300 | Trans-NIH Recovery Act Research Support This is a supplement to fund a service provider to collect data on participants unable to come to a clinical center. This will decrease the amount of missing data in the Longitudinal Assessment of Bariatric Surgery (LABS) consortium. The LABS consortium | National Institutes of Health | 8/13/2010 |
UNIVERSITY OF PITTSBURGH THE | $333,245 |
Trans-NIH Recovery Act Research Support The overall goal of the project is to validate specific protein biomarkers for amyotrophic lateral sclerosis (ALS). ALS is a fatal motor neuron disease that can strike adults of any age, yet we know little about its causes and cannot rapidly diagnose
This spending item is part of a $876,706 allocation.
See details
|
National Institutes of Health | 9/21/2009 |
CARNEGIE MELLON UNIVERSITY | $333,151 | Trans-NIH Recovery Act Research Support Among the many problems arising from cell biology and medicine, shape phenotype mapping (the detailed measurement of shape related quantities from cells and subcellular organelles) from microscopy images has received particular attention in the past due t | National Institutes of Health | 9/30/2009 |
CARNEGIE MELLON UNIVERSITY | $333,151 | Trans-NIH Recovery Act Research Support Among the many problems arising from cell biology and medicine, shape phenotype mapping (the detailed measurement of shape related quantities from cells and subcellular organelles) from microscopy images has received particular attention in the past due t | National Institutes of Health | 9/30/2009 |
UNIVERSITY OF PITTSBURGH THE | $331,753 | Trans-NIH Recovery Act Research Support Older adults with a history of depression seem to be at increased risk of developing progressive dementia. The reasons for this increased risk are not well understood. This supplemental study to an ongoing research grant (R01 MH072947) will gather informa | National Institutes of Health | 7/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $330,511 | The University of Pittsburgh has been awarded a contract to provide tumor types to the NCI for The Cancer Genome Atlas (TCGA) project. Specifically this award is to fund the provision of renal clear cell tissues (200 additional cases) under delivery orde | National Institutes of Health | 5/12/2010 |
UNIVERSITY OF PITTSBURGH THE | $327,110 | Trans-NIH Recovery Act Research Support Elucidation of the physiological regulation of a prototypical member of receptor tyrosine kinases of the ErbB family, epidermal growth factor receptor (EGFR/ErbB1) is the key to understanding the mechanisms causing its oncogenic activation. EGFR initiates | National Institutes of Health | 6/16/2010 |
Young Women's Christian Association of Greater Pittsburgh | $326,041 |
ARRA Child Care and Development Block Grant The American Recovery and Reinvestment Act (ARRA) Child Care and Development Fund (CCDF) funds have two mandatory earmarks, Infant/Toddler and Quality. The Infant/Toddler funds are utilized for new center-based Keystone Babies programs. Specifically, th
This spending item is part of a $60,146,767 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
UNIVERSITY OF PITTSBURGH THE | $320,902 | Trans-NIH Recovery Act Research Support Title: The contribution of DNA interstrand crosslinks to Aging RO1 ES016114 This is a supplement to an existing RO1 from NIEHS. The purpose of this project is to test the hypothesis that the cellular response to crosslinking agents is determined at leas | National Institutes of Health | 9/06/2009 |
UNIVERSITY OF PITTSBURGH THE | $314,744 |
Trans-NIH Recovery Act Research Support The 'Utilization of Principles of Community-Based Participator Research (CBPR) and Concept Mapping to Foster and Inform Community Engaged Research' project is an important initiative that will further increase awareness about the community based participa
This spending item is part of a $599,968 allocation.
See details
|
National Institutes of Health | 8/24/2009 |
MAGEE-WOMENS HEALTH CORPORATION | $311,334 | Trans-NIH Recovery Act Research Support DESCRIPTION (provided by applicant): The purpose of this proposal is to demonstrate the capabilities of the University of Pittsburgh to participate as a Clinical site in a NICHD-sponsored network addressing Preterm Birth in Nulliparous Women (Nullipara Ne | National Institutes of Health | 7/08/2010 |
MAGEE-WOMENS HEALTH CORPORATION | $311,334 | Trans-NIH Recovery Act Research Support DESCRIPTION (provided by applicant): The purpose of this proposal is to demonstrate the capabilities of the University of Pittsburgh to participate as a Clinical site in a NICHD-sponsored network addressing Preterm Birth in Nulliparous Women (Nullipara Ne | National Institutes of Health | 7/08/2010 |
SQUIRREL HILL HEALTH CENTER | $310,725 | ARRA Health Center Integrated Services Development Initiative[g1] Grant Name: Capital Improvement Program (CIP) Purpose: To build a mobile medical unit and to upgrade the electronic health record. Goals: 1) To build a mobile medical unit to increase access to regular primary care for patients who lalack access to regular... Show more | Health Resources and Services Administration | 6/25/2009 |
UNIVERSITY OF PITTSBURGH THE | $309,926 |
Trans-NIH Recovery Act Research Support As a systemic disease of the vessel wall, atherosclerosis occurs in carotid, coronary and peripheral arteries, and has contributes to significant morbidity and mortality in the adult population. Recent advances in basic sciences have established a fundame
This spending item is part of a $424,679 allocation.
See details
|
National Institutes of Health | 5/29/2009 |
CARNEGIE MELLON UNIVERSITY | $306,482 |
Trans-NIH Recovery Act Research Support This project addresses broad Challenge Area: Enabling Technologies, Challenge Topic 06-HD-101, Improved Interfaces for Prostheses to Impact Rehabilitation Outcomes. Recent advances in decoding motor intentions and the technology to record populations o
This spending item is part of a $1,000,000 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
UNIVERSITY OF PITTSBURGH THE | $305,278 | Trans-NIH Recovery Act Research Support This grant is an ARRA administrative supplement to 2-R01-DE016148 (Extending the Phenotype of Nonsyndromic Orofacial Clefts). This supplement adds a new collaboration that will add facial movement studies to the project. Through this new collaboration | National Institutes of Health | 9/01/2009 |
UNIVERSITY OF PITTSBURGH THE | $304,250 | ARRA Health Center Integrated Services Development Initiative[g1] The purpose of this grant is to enable community health centers and federally qualified health centers such as the Matilda Theiss Health Center (MTHC) to improve facilities in anticipation of an increase in demand for services during t the economic downturn... Show more | Health Resources and Services Administration | 6/25/2009 |
UNIVERSITY OF PITTSBURGH THE | $303,000 | Trans-NIH Recovery Act Research Support The Administrative Supplement provides funding for two aspects of our rapidly expanding studies in the field of cancer-induced immune suppression. The proposed additional studies focus on newly discovered and potentially critically important mechanisms o | National Institutes of Health | 8/31/2009 |
FLUOROUS TECHNOLOGIES, INC | $302,565 |
Trans-NIH Recovery Act Research Support Project Title: Fluorous Solution-Phase Synthesis of Peptides and Oligosaccharides. This Administrative supplement seeks to expand upon the Specific Aims of the original grant by enabling: 1) Continued development of synthetic methods for fluorous peptide
This spending item is part of a $495,644 allocation.
See details
|
National Institutes of Health | 9/04/2009 |
Young Women's Christian Association of Greater Pittsburgh | $301,035 |
ARRA Child Care and Development Block Grant The American Recovery and Reinvestment Act (ARRA) Child Care and Development Fund (CCDF) funds have two mandatory earmarks, Infant/Toddler and Quality. The Infant/Toddler funds are utilized for new center-based Keystone Babies programs. Specifically, th
This spending item is part of a $60,146,767 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
UNIVERSITY OF PITTSBURGH THE | $300,000 | Trans-NIH Recovery Act Research Support This is a supplement to the existing grant. This supplemental award has been directed toward developing safe radiation damage mitigator compounds (drugs which work after radiation exposure but before the onset of radiation damage syndrome), to pregnant f | National Institutes of Health | 9/21/2009 |
UNIVERSITY OF PITTSBURGH THE | $300,000 | ARRA ? Equipment to Enhance Training for Health Professionals Project Title: A Multi-Campus Initiative to Increase Baccalaureate Nursing Program Enrollment. The proposed project will expand enrollment in the baccalaureate nursing program by establishing a new program site within the structure of thehe University of P... Show more | Health Resources and Services Administration | 9/02/2010 |
UNIVERSITY OF PITTSBURGH THE | $300,000 | Trans-NIH Recovery Act Research Support This is one-year bridge funding for the renewal of a study investigating functional aging, or disability-free survival by examining long-term survivors of the Cardiovascular Health Study to determine the likelihood of maintaining function, identify the tr | National Institutes of Health | 9/24/2010 |
CARNEGIE MELLON UNIVERSITY | $297,764 | Trans-NIH Recovery Act Research Support The goal of the NIGMS-MARC parent grant is to establish bioinformatics teaching and research on partner minority campuses through a four part program involving: - Training an interdisciplinary group of faculty at minority serving institutions in the field | National Institutes of Health | 9/08/2009 |
UNIVERSITY OF PITTSBURGH THE | $297,513 | Trans-NIH Recovery Act Research Support The overall purpose of this competitive revision is to extend the scope of the currently funded Pocket PATH project beyond patient behaviors to also support the clinician behaviors known to promote better health outcomes through collaboration and partners | National Institutes of Health | 9/18/2009 |
UNIVERSITY OF PITTSBURGH THE | $296,349 | ARRA ? Equipment to Enhance Training for Health Professionals The ARRA - Equipment to Enhance Training for Health Professionals grant is awarded for the purchase of a total of six equipment units for the sum of $296,349, separately invoiced. The purpose of the equipment is to capture, edit, broadcastst, and store cont... Show more | Health Resources and Services Administration | 9/02/2010 |
UNIVERSITY OF PITTSBURGH THE | $296,114 |
Trans-NIH Recovery Act Research Support The present application takes advantage of the high quality data that already exist and proposes a study that can be completed within 2 years (at a cost of $737,367). It will combine data from the youngest PYS cohort from ages 7 through 25 with data from
This spending item is part of a $723,722 allocation.
See details
|
National Institutes of Health | 5/07/2009 |
UNIVERSITY OF PITTSBURGH THE | $295,423 |
Trans-NIH Recovery Act Research Support Chikungunya virus (CHIKV), an Alphavirus in the family Togaviridae, causes sporadic, but explosive epidemics of mosquito-borne disease in humans. The symptoms are almost indistinguishable from dengue fever, with acute febrile illness and associated crippl
This spending item is part of a $429,298 allocation.
See details
|
National Institutes of Health | 2/03/2010 |
BLUE BELT TECHNOLOGIES, INC. | $295,097 | Trans-NIH Recovery Act Research Support The proposed brain probe will permit intracranial hematomas (large blood clots on the brain) to be surgically evacuated in a minimally invasive manner in the Intensive Care Unit under a local anesthetic. This surgical treatment will be navigated and utili | National Institutes of Health | 5/07/2009 |
DUQUESNE UNIVERSITY OF THE HOLY SPIRIT | $292,489 |
Trans-NIH Recovery Act Research Support DESCRIPTION (provided by applicant): Despite decades of committed research, no agents are clinically available to combat psychostimulant abuse and addiction. This prodigious void can be linked to sparse information on the 3-D structure and function of the
This spending item is part of a $332,560 allocation.
See details
|
National Institutes of Health | 5/18/2009 |
UNIVERSITY OF PITTSBURGH THE | $290,211 | Trans-NIH Recovery Act Research Support This proposal seeks supplemental funding through the Recovery Act to extend the Specific Aim #2 of the parent grant. Our long-term objective is to elucidate the endocytic trafficking pathways of the Cystic Fibrosis Transmembrane Conductance Regulator (CFT | National Institutes of Health | 7/16/2009 |
UNIVERSITY OF PITTSBURGH THE | $290,204 | Trans-NIH Recovery Act Research Support This is a facility improvement project specifically to accomplish the following: 1.To ensure the occupational health and safety of personnel and to provide enhanced research animal communicable disease prevention through replacement of obsolete and/or un | National Institutes of Health | 8/27/2009 |
UNIVERSITY OF PITTSBURGH THE | $288,855 | Trans-NIH Recovery Act Research Support This is a supplement to fund the systematic coding of medication data collected in the Study of Women's Health Across the Nation (SWAN) and the creation of datasets to streamline analyses to improve scientific productivity. In addition, the medication da | National Institutes of Health | 9/18/2009 |
UNIVERSITY OF PITTSBURGH THE | $271,288 | Trans-NIH Recovery Act Research Support Through the hiring of two new research associates, the requested support will enable us to enhance research goals and capacities through infrastructure support for mulitple investigators by increasing the number of human brains available for study, accel | National Institutes of Health | 9/28/2009 |
UNIVERSITY OF PITTSBURGH THE | $270,758 | Trans-NIH Recovery Act Research Support This is a two-year extension of the Study of Osteoporotic Fractures (SOF) to analyze data, publish results, and continue scientific participation in SOF during the 4th and 5th years of our competitively renewed and (partially) funded 5 year study. We are | National Institutes of Health | 9/04/2009 |
FISHER SCIENTIFIC COMPANY L.L.C. | $267,123 |
The overall purpose of the ARRA funds received by Merck is to provide the CDC Project grantees vaccines for their respective Immunization Programs. In some instances, the ARRA funds will provide vaccines that would cover a budget shortfall in the program
This spending item is part of a $10,807,046 allocation.
See details
|
Centers for Disease Control and Prevention | 7/01/2009 |
UNIVERSITY OF PITTSBURGH THE | $261,790 | Trans-NIH Recovery Act Research Support The Duffy antigen, a minor blood group antigen, binds multiple chemokines with high affinity and is one potential modifier of lung and systemic inflammation located at tissue sites (endothelium) and in the vascular space (erythrocytes). We have recently | National Institutes of Health | 8/25/2009 |
UNIVERSITY OF PITTSBURGH THE | $261,772 | Trans-NIH Recovery Act Research Support HIV infected persons have an increased incidence of emphysema compared to those without HIV infection, and it has been hypothesized that this accelerated disease progression is the result of one or more latent infectious agents that amplify the fulmonary | National Institutes of Health | 7/16/2009 |
UNIVERSITY OF PITTSBURGH THE | $257,357 | Trans-NIH Recovery Act Research Support These funds will focus on expanding the Pilot and Feasibility program and purchasing equipment to support ongoing and pending obesity-related research at the University of Pittsburgh. | National Institutes of Health | 7/20/2009 |
ALLEGHENY-SINGER RESEARCH INSTITUTE | $254,171 | Trans-NIH Recovery Act Research Support Chronic middle ear infections including otitis media with effusion and recurrent otitis media are two of the most common reasons that children visit a doctor, receive antibiotics and undergo general anesthesia and surgery. These infections are caused by s | National Institutes of Health | 8/14/2009 |
Focus On Renewal - Sto-Rox Neighborhood Corporation | $253,096 |
ARRA - Early Head Start The University of Pittsburgh Office of Child Development will provide Early Head Start services to families with infant and toddlers. The model is primarily home-based with children within Allegheny County. The primary communities are the city of Clairton
This spending item is part of a $2,639,588 allocation.
See details
|
Administration for Children and Families | 11/19/2009 |
UNIVERSITY OF PITTSBURGH THE | $251,490 |
Trans-NIH Recovery Act Research Support Fluorescent in situ hybridization (FISH) imaging has been proven as a powerful molecular imaging tool to detect cancers, predict cancer prognosis, and monitor therapy efficacy. However, manual FISH analytic method is a tedious procedure, and introducing i
This spending item is part of a $824,927 allocation.
See details
|
National Institutes of Health | 8/04/2009 |
UNIVERSITY OF PITTSBURGH THE | $248,502 |
Trans-NIH Recovery Act Research Support In this proposal, we used advanced magnetic resonance imaging (MRI) technology to visualize the trafficking of cellular immunotherapy against colorectal cancer. Most often applied to advanced cancer, where existing therapies have limited efficacy, cellul
This spending item is part of a $976,850 allocation.
See details
|
National Institutes of Health | 5/05/2009 |
UNIVERSITY OF PITTSBURGH THE | $246,371 | Trans-NIH Recovery Act Research Support Respiratory infection has been associated with various lung diseases such as pneumonia, cystic fibrosis, and tuberculosis. Annual economic costs of respiratory tract infections in the United States are conservatively estimated to exceed 15 billion dollar | National Institutes of Health | 7/16/2009 |
UNIVERSITY OF PITTSBURGH THE | $246,317 | Trans-NIH Recovery Act Research Support UPCI has been developing a Small Animal Imaging Facility as an additional component of the In Vivo Imaging Shared Facility, a part of the Cancer Center Support Grant (CCSG). This Administrative Supplement entitled Contrast Enhanced Ultrasound Imaging of V | National Institutes of Health | 9/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $245,890 | Trans-NIH Recovery Act Research Support We are requesting funds to supplement our ongoing project '5R01AI76060- 3 Immunization Strategies for Autologous HIV Immunotherapy'. The goal of the parent project is to develop an effective antigen-specific HIV immunotherapy. Our approach is to obviate c | National Institutes of Health | 5/17/2010 |
UNIVERSITY OF PITTSBURGH THE | $245,244 |
Trans-NIH Recovery Act Research Support Methicillin-Resistant Staphylococcus aureus (MRSA) produces significant morbidity and mortality among a large and growing population of hospitalized and chronically ill patients in the US. As invasive disease due to MRSA continues to rise, there is an urg
This spending item is part of a $1,248,355 allocation.
See details
|
National Institutes of Health | 8/30/2010 |
UNIVERSITY OF PITTSBURGH THE | $243,027 |
Trans-NIH Recovery Act Research Support The objective of the NIH Grant Number R01EY009859 is to identify the genetic basis of age-related Maculopathy (GARM). This project is committed to the prospective study of genetic, environmental and early clinical risk factors for the development of macul
This spending item is part of a $730,926 allocation.
See details
|
National Institutes of Health | 9/23/2009 |
UNIVERSITY OF PITTSBURGH THE | $242,000 | Trans-NIH Recovery Act Research Support Using observational study designs we will examine the following two objectives: Objective 1 is to determine the impact of antihypertensives on self-reported urinary incontinence. One specific hypothesis to be tested is that the use of certain antihypert | National Institutes of Health | 9/21/2010 |
DUQUESNE UNIVERSITY OF THE HOLY SPIRIT | $239,920 |
Trans-NIH Recovery Act Research Support Mechanisms for Arsenic-Induced Vascular Disease In response to NOT-OD-09-058: NIH Announces the Availability of Recovery Act for Competitive Revision Applications; this is an application for a competitive revision to expand scope of the aims for 5R01-ES0
This spending item is part of a $741,303 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
UNIVERSITY OF PITTSBURGH THE | $237,923 |
Trans-NIH Recovery Act Research Support The major focus of the project is to determine whether immune cell senescence (as assessed by telomere length) plays an important role in our ability to fight off infection. Because life stress has been found to be associated with greater senescence, we
This spending item is part of a $447,911 allocation.
See details
|
National Institutes of Health | 9/16/2009 |
CARNEGIE MELLON UNIVERSITY | $236,931 |
Trans-NIH Recovery Act Research Support This project proposes to test a novel strategy financial incentives to improve uptake of comparative effectiveness findings among physicians and patients to reduce cardiovascular risk. This project will focus on improving cholesterol control among
This spending item is part of a $12,488,763 allocation.
See details
|
National Institutes of Health | 9/16/2010 |
UNIVERSITY OF PITTSBURGH THE | $234,240 | Trans-NIH Recovery Act Research Support The overall goal of this ACC and accompanying equipment supplement (EQ) is to modernize an 11-year old custom-build setup for the mapping of functional connectivity in brainstem slices (glutamate uncaging system) and to request funds to employ a post-doc | National Institutes of Health | 7/10/2009 |
UNIVERSITY OF PITTSBURGH THE | $234,160 | Trans-NIH Recovery Act Research Support It has been recently discovered that in addition to resident tenocytes, tendons host another population of cells, termed tendon stem cells (TSCs). TSCs are characterized by their multidifferentiation potential, including non-tenocyte lineages, such as ad | National Institutes of Health | 9/18/2009 |
DUQUESNE UNIVERSITY OF THE HOLY SPIRIT | $230,738 | Trans-NIH Recovery Act Research Support We will develop a suite of programs aimed at improving K-12 and the general public's understanding of health science advances created by National Institutes of Health funded clinical and basic research in the areas of stem cell biology and regenerative m | National Institutes of Health | 9/07/2009 |
UNIVERSITY OF PITTSBURGH THE | $230,569 | Trans-NIH Recovery Act Research Support There are very few reports of genomic studies performed in squamous cell carcinoma of the head and neck (SCCHN). The Cancer Genome Atlas has prioritized selected tumors for sequencing and SCCHN is not included in the cancer types sequenced to date or iden | National Institutes of Health | 8/31/2009 |
CELLOMICS, INC. | $227,856 | **Recovery Order** Array Scan VTI HCS Reader Bundle & Accessories | National Institutes of Health | 6/30/2009 |
UNIVERSITY OF PITTSBURGH THE | $227,250 | Trans-NIH Recovery Act Research Support Previous studies using PET and SPECT endogenous competition binding techniques have shown that chronic cocaine users relative to healthy controls release less dopamine following an acute amphetamine challenge. A likely explanation for a decrease in DA tra | National Institutes of Health | 5/04/2009 |
UNIVERSITY OF PITTSBURGH THE | $227,250 | Trans-NIH Recovery Act Research Support The parent grant, GM077872, focused on three major issues dealing with various aspects of the study of helicases and translocation activities of PcrA helicase using single molecule approaches. Helicases are ubiquitous enzymes present in all living cells t | National Institutes of Health | 9/30/2009 |
UNIVERSITY OF PITTSBURGH THE | $227,250 | Trans-NIH Recovery Act Research Support The main goal of the proposed research is to elucidate the mechanisms that regulate PTH1R endocytosis and intracellular traffic. Previous work from our laboratory and others has shown that the PTH1R is internalized by a combination of arrestin-dependent a | National Institutes of Health | 2/19/2010 |
UNIVERSITY OF PITTSBURGH THE | $227,250 | Trans-NIH Recovery Act Research Support This award serves as bridge funding in conjunction with the R01 application (1R01DK083284-01A1) for the purpose of generating additional data and development of methodologies in support of the R01 resubmission. The grant activities are dedicated to eluci | National Institutes of Health | 4/15/2010 |
UNIVERSITY OF PITTSBURGH THE | $226,553 |
Trans-NIH Recovery Act Research Support Xenotransplantation may be clinically feasible once the molecular barriers between species and mechanisms of graft loss or rejection are better understood. Xenograft survival would have to be also achieved without compromising the recipient to the extent
This spending item is part of a $982,867 allocation.
See details
|
National Institutes of Health | 8/28/2009 |
UNIVERSITY OF PITTSBURGH THE | $224,578 | Trans-NIH Recovery Act Research Support The parental proposal aims to study the in vivo binding specificity of certain types of transcription factors (TFs). The TFs we are interested in are those that by themselves they have relatively weak binding, and depend on co-factors to achieve the neede | National Institutes of Health | 9/03/2009 |
UNIVERSITY OF PITTSBURGH THE | $218,268 | Trans-NIH Recovery Act Research Support The requested administrative supplement will be used to support the full time employment of a senior level research scientist (Level IV) and to procure new equipment needed for the specialized PCR based assay that is required for the project. The purpose | National Institutes of Health | 8/15/2009 |
UNIVERSITY OF PITTSBURGH THE | $218,229 |
Trans-NIH Recovery Act Research Support The purpose of this proposal is to establish an Obstetric-Fetal-Pharmacology Research Unit (OPRU) at the University of Pittsburgh and to summarize the components of the applicant's OPRU. They will demonstrate their willingness to cooperate with other OPRU
This spending item is part of a $396,320 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
UNIVERSITY OF PITTSBURGH THE | $217,930 |
Trans-NIH Recovery Act Research Support Sickle cell anemia is a devastating disease affecting primarily African Americans. Our goals are to capture the genetic diversity that is likely to underlie the notoriously heterogeneous clinical course of this disease, and with this information, develop
This spending item is part of a $2,981,256 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
UNIVERSITY OF PITTSBURGH THE | $216,535 |
Trans-NIH Recovery Act Research Support In this administrative supplement, consistent with the NIH-wide emphasis on personalized medicine, we will develop methods for creating comprehensive profiles of treatment outcomes in major depression with the goal of simultaneously capturing multiple asp
This spending item is part of a $249,954 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
UNIVERSITY OF PITTSBURGH THE | $215,672 | Trans-NIH Recovery Act Research Support This is a competitive supplement awarded through the American Recovery and Reinvestment Act mechanism to expand the goals of the parent U01. Quantitative MS assays for the INIA-West gene target proteins will be developed to facilitate high-throughput quan | National Institutes of Health | 4/08/2011 |
CARNEGIE MELLON UNIVERSITY | $215,081 |
Trans-NIH Recovery Act Research Support This project is one of three that compose the University of Pittsburgh Autism Center of Excellence (ACE). The Pittsburgh ACE is learning more about brain differences in autism and how individuals with autism process information. This administrative supp
This spending item is part of a $400,722 allocation.
See details
|
National Institutes of Health | 9/22/2009 |
UNIVERSITY OF PITTSBURGH THE | $214,057 | Trans-NIH Recovery Act Research Support The objectives of the proposed research are to identify proteins that play general and important roles in transcription by RNA polymerase II (pol II) and to elucidate the mechanisms by which these proteins act. This grant focuses on the highly regulated | National Institutes of Health | 9/30/2009 |
UNIVERSITY OF PITTSBURGH THE | $213,682 | Trans-NIH Recovery Act Research Support Myocardial infarction (MI) is the leading cause of death in the world. The most common causes are blockages that restrict blood supply to the heart, leading to ischemic damage and necrosis. In response to MI, a repair mechanism ensues involving engulfment | National Institutes of Health | 7/16/2009 |
UNIVERSITY OF PITTSBURGH THE | $213,625 | Trans-NIH Recovery Act Research Support Contributions to the airway surface liquid (ASL) come from both constitutive and stimulated secretion, with CFTR considered the source of both constitutive and cAMP/PKA-stimulated anion secretion. Specific members of the SLC26A family of transporters faci | National Institutes of Health | 9/30/2010 |
UNIVERSITY OF PITTSBURGH THE | $210,835 |
Trans-NIH Recovery Act Research Support The NIDDK provides funding to four different basic science consortia. Each of these groups has established an informatics infrastructure, but has done so independently. This poses major limitations for the NIDDK since there is no direct way for visitors
This spending item is part of a $2,595,935 allocation.
See details
|
National Institutes of Health | 7/27/2009 |
UNIVERSITY OF PITTSBURGH THE | $210,612 | Trans-NIH Recovery Act Research Support We previously reported a significant association between HHV-8 infection and prostate cancer risk in the Caribbean island of Tobago. We have also demonstrated HHV-8 protein expression in the non-cancerous prostates of U.S. Caucasian men who are HHV-8 ser | National Institutes of Health | 9/15/2009 |
CARNEGIE MELLON UNIVERSITY | $209,988 |
Trans-NIH Recovery Act Research Support The major focus of the project is to determine whether immune cell senescence (as assessed by telomere length) plays an important role in our ability to fight off infection. Because life stress has been found to be associated with greater senescence, we
This spending item is part of a $447,911 allocation.
See details
|
National Institutes of Health | 9/16/2009 |
UNIVERSITY OF PITTSBURGH THE | $207,825 | Trans-NIH Recovery Act Research Support Although hypoxic pulmonary vasoconstriction (HPV) has been reported to affect all segments of the pulmonary circulation relatively little is known regarding vasoconstriction of small (<50um) intra-acinar arterioles. Our preliminary data suggest that hypo | National Institutes of Health | 7/16/2009 |
UNIVERSITY OF PITTSBURGH THE | $203,529 | Trans-NIH Recovery Act Research Support We originally cloned SAFB1 as a transcriptional repressor, and it has since been implicated in a number of processes including hormone response, and transformation. The SAFB1 gene shows extremely high rates of loss of heterozygosity in breast cancer, and | National Institutes of Health | 5/10/2011 |
UNIVERSITY OF PITTSBURGH THE | $202,276 |
ARRA - Strategic Health IT Advanced Research Projects (SHARP) We propose research that will generate a framework of open source services that can be dynamically configured to transform HER data into standards-conforming, comparable information suitable for large-scale analyses, inferencing, and integegration of dispar... Show more
This spending item is part of a $15,000,000 allocation.
See details
|
Health and Human Services, Department of | 3/19/2010 |
EAST LIBERTY FAMILY HEALTH CARE CENTER | $201,704 | ARRA Health Center Integrated Services Development Initiative[g1] ARRA - INCREASED SERVICES TO HEALTH CENTER | Health Resources and Services Administration | 3/23/2009 |
Brightside Academy | $199,857 |
ARRA Child Care and Development Block Grant The American Recovery and Reinvestment Act (ARRA) Child Care and Development Fund (CCDF) funds have two mandatory earmarks, Infant/Toddler and Quality. The Infant/Toddler funds are utilized for new center-based Keystone Babies programs. Specifically, th
This spending item is part of a $60,146,767 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
JWMC, LLC. | $199,404 | Trans-NIH Recovery Act Research Support Clinical encounters require the creation of an enormous amount of documentation. This documentation is tedious, time-consuming, and, in practice, is usually created hours after the encounter has occurred. The requirement to create this documentation place | National Institutes of Health | 8/19/2010 |
UNIVERSITY OF PITTSBURGH THE | $198,774 | Trans-NIH Recovery Act Research Support The purpose of this application is to request funds for a Recovery Act Administrative Supplement to increase the tempo of scientific research of NIH Grant R-01 DK078500, A New Dimension in Renal Clearance Design Criteria for Dendrimer Nanostructures, | National Institutes of Health | 8/31/2009 |
COGNITION THERAPEUTICS, INC. | $198,376 | Trans-NIH Recovery Act Research Support Small Molecule Oligomer Formation Inhibitors | National Institutes of Health | 6/15/2010 |
UNIVERSITY OF PITTSBURGH THE | $198,102 | Trans-NIH Recovery Act Research Support The purpose of this project is to further disseminate inquiry-based laboratory exercises developed in our SEPA project by (a) adding a Program Coordinator who will double our capacity to conduct in-school visits for student use of the exercises; (b) deplo | National Institutes of Health | 8/31/2009 |
UNIVERSITY OF PITTSBURGH THE | $197,708 | Trans-NIH Recovery Act Research Support This competitive revision is in response to the Notice Number (NOT-OD-09-058) and Notice Title: NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications, for the parent grant (R01CA121105) entitled SMAC in chemoprevention | National Institutes of Health | 9/18/2009 |
UNIVERSITY OF PITTSBURGH THE | $197,530 | Trans-NIH Recovery Act Research Support Award Description (one-time requirement unless there is a shift in goals from initial intent): Coronary heart disease is the leading cause of premature disability and death in the United States and other industrialized nations. The progression of heart d | National Institutes of Health | 8/10/2009 |
UNIVERSITY OF PITTSBURGH THE | $193,986 |
Trans-NIH Recovery Act Research Support This application addresses broad Challenge Area (06) Enabling Technologies, 06-NS-106: Validating new methods to study brain connectivity. We propose to test a new method that provides substantial improvement over previous Cre-conditional viral tracers. T
This spending item is part of a $992,745 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
CAPINTEC INC | $193,750 | dual hot cells | National Institutes of Health | 9/27/2009 |
ALLEGHENY, COUNTY OF | $192,186 |
Aging Congregate Nutrition Services for States The American Recovery and Reinvestment Act (ARRA) provided funding for congregate nutrition services. Established in 1972 under the Older Americans Act, the program provides meals to older Americans in congregate facilities such as senior centers, adultlt ... Show more
This spending item is part of a $3,005,971 allocation.
See details
|
Administration on Aging | 3/18/2009 |
UNIVERSITY OF PITTSBURGH THE | $191,634 | Trans-NIH Recovery Act Research Support The parent application for this administrative supplement focuses on the mechanism by which inhaled carbon monoxide (CO) exerts its therapeutic actions in the mouse model of experimental pulmonary hypertension. In the process of conducting related experim | National Institutes of Health | 7/16/2009 |
UNIVERSITY OF PITTSBURGH THE | $190,972 |
Trans-NIH Recovery Act Research Support The Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) Study is an expansion of the Orinda. Longitudinal Study of Myopia (OLSM). The original, single-center study started in Orinda, California in 1989, and the three CLEERE cl
This spending item is part of a $1,048,712 allocation.
See details
|
National Institutes of Health | 9/11/2009 |
UNIVERSITY OF PITTSBURGH THE | $189,375 | Trans-NIH Recovery Act Research Support The coat protein complex II (COPII) mediates the sorting and export of cargo proteins from the endoplasmic reticulum (ER). We combine well-defined in vitro experimental systems that reconstitute COPII activities on ER membranes and liposomes, with cellula | National Institutes of Health | 8/18/2009 |
UNIVERSITY OF PITTSBURGH THE | $189,375 | Trans-NIH Recovery Act Research Support Alcohol abuse and consumption are major causes of liver disease and is a major health problem in the United States. The characteristics of this disease are fatty liver, hepatitis, fibrosis, and cirrhosis. Cirrhosis is the eleventh leading cause of death i | National Institutes of Health | 8/17/2009 |
NSABP FOUNDATION, INC. | $188,932 | Trans-NIH Recovery Act Research Support The American Cancer Society estimated that in 2004, breast or colorectal cancer would strike over 350,000 Americans and close to 100,000 people would die from these diseases. The National Surgical Adjuvant Breast and Bowel Project(NSABP) is a multi-center | National Institutes of Health | 7/02/2010 |
NSABP FOUNDATION, INC. | $188,932 | Trans-NIH Recovery Act Research Support The American Cancer Society estimated that in 2004, breast or colorectal cancer would strike over 350,000 Americans and close to 100,000 people would die from these diseases. The National Surgical Adjuvant Breast and Bowel Project(NSABP) is a multi-center | National Institutes of Health | 7/02/2010 |
UNIVERSITY OF PITTSBURGH THE | $187,616 |
Trans-NIH Recovery Act Research Support The Specific Aims of R01 AI071846 Rational Design of NRTI for Drug Resistant HIV-1 are to: (1)synthesize novel base modified 3'-azido-2',3'-dideoxypurines (ADPs) and to systematically identify the most potent compounds using a multi-disciplinary approach
This spending item is part of a $486,282 allocation.
See details
|
National Institutes of Health | 5/24/2010 |
UNIVERSITY OF PITTSBURGH THE | $181,049 | Trans-NIH Recovery Act Research Support Parkinsons disease (PD) poses a serious threat to the health of a large segment of our society. The present project focuses on strategies for inducing endogenous neuroprotective mechanisms in animal models of the dopamine (DA) deficiency associated with P | National Institutes of Health | 9/28/2009 |
CARNEGIE MELLON UNIVERSITY | $180,529 | Trans-NIH Recovery Act Research Support The activities included in the parent grant, 1 R21 EB008804-01A2, which encompass those proposed in this supplemental request, are based on the implementation of the clinical research study from which data is gathered for the application of the FSI comput | National Institutes of Health | 7/15/2009 |
CARNEGIE MELLON UNIVERSITY | $180,529 | Trans-NIH Recovery Act Research Support The activities included in the parent grant, 1 R21 EB008804-01A2, which encompass those proposed in this supplemental request, are based on the implementation of the clinical research study from which data is gathered for the application of the FSI comput | National Institutes of Health | 7/15/2009 |
UNIVERSITY OF PITTSBURGH THE | $180,000 |
Trans-NIH Recovery Act Research Support This collaborative application is submitted in response to RFA MH-09-171. The root causes of autism remain unknown, limiting efforts to understand disease heterogeneity, diagnose cases, and prevent and treat disease. Epidemiological findings have repeated
This spending item is part of a $1,412,032 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
UNIVERSITY OF PITTSBURGH THE | $179,323 | Trans-NIH Recovery Act Research Support The goals of the project are to investigate the roles of B cell activation and B cell subsets in driving development of T cell memory and allograft rejection, and whether B cell depletion would inhibit these processes and promote allograft survival. The a | National Institutes of Health | 7/19/2010 |
MAGEE-WOMENS HEALTH CORPORATION | $178,091 |
Trans-NIH Recovery Act Research Support The purpose of this proposal is to establish an Obstetric-Fetal-Pharmacology Research Unit (OPRU) at the University of Pittsburgh and to summarize the components of the applicant's OPRU. They will demonstrate their willingness to cooperate with other OPRU
This spending item is part of a $396,320 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
UNIVERSITY OF PITTSBURGH THE | $177,489 |
Trans-NIH Recovery Act Research Support Proper regulation of NF-KB transcription factors is critical for the mounting of immune responses to pathogens and for the normal homeostasis of the immune system. In this light, it is important to know how NF-KB family transcription factors are controlle
This spending item is part of a $355,013 allocation.
See details
|
National Institutes of Health | 8/31/2009 |
UNIVERSITY OF PITTSBURGH THE | $176,682 | Trans-NIH Recovery Act Research Support The award issued under the American Recovery and Reinvestment for the period 7/01/10-6/30/11 is an administrative supplement to Dr. Costantinos grant entitled Biostatistical Center for the NSABP. The National Surgical Adjuvant Breast and Bowel Project (NS | National Institutes of Health | 7/02/2010 |
ALLEGHENY, COUNTY OF | $176,006 |
Aging Home-Delivered Nutrition Services for States ARRA funding of home delivered nutrition services will augment existing resources, replace revenue lost from local resources due to the economic downturn and support the continued delivery of meals to vulnerable older Americans. Home delivered mealsls help... Show more
This spending item is part of a $1,479,863 allocation.
See details
|
Administration on Aging | 3/18/2009 |
Informing Design Inc | $174,273 |
ARRA - Prevention and Wellness--Communities Putting Prevention to Work The Communities Putting Prevention to Work award is utilized for a community-wide initiative to reduce obesity. By increasing consumption of fruits and vegetables and decreasing intake of transfats, salt and sugary beverages, The e Metro Public Health Depar... Show more
This spending item is part of a $7,527,527 allocation.
See details
|
Centers for Disease Control and Prevention | 3/19/2010 |
UNIVERSITY OF PITTSBURGH THE | $173,922 | Trans-NIH Recovery Act Research Support The University of Pittsburgh Brain Trauma Research Center is funded to investigate the molecular and cellular mechanisms of secondary brain injury (physiologic and neurochemical responses of the injured brain). Our studies have lead to an improved underst | National Institutes of Health | 9/24/2009 |
UNIVERSITY OF PITTSBURGH THE | $169,189 |
Trans-NIH Recovery Act Research Support Transplantation is the ideal therapy for end stage heart and end stage kidney failure, but allograft survival and function remain suboptimal. This CTOT renewal application will build upon the findings resulting from the previous 4 years of studying biomar
This spending item is part of a $9,955,156 allocation.
See details
|
National Institutes of Health | 9/13/2010 |
UNIVERSITY OF PITTSBURGH THE | $168,154 | Trans-NIH Recovery Act Research Support The goals of this supplement are to (i) better define the frequency of emergence of N348I in non-B HIV-1 subtypes (C, A, D, other) in patients on failing first-line regimens and determine whether the selection of N348I is driven by specific antiretroviral | National Institutes of Health | 9/27/2010 |
UNIVERSITY OF PITTSBURGH THE | $167,810 | Trans-NIH Recovery Act Research Support Dendritic cells (DC) are innate immune system cells that are critical in the host response to viral infection. DC are actively recruited to inflamed lymphoid and mucosal tissues where they produce inflammatory and antiviral cytokines and stimulate antigen | National Institutes of Health | 9/21/2009 |
UNIVERSITY OF PITTSBURGH THE | $167,226 | Trans-NIH Recovery Act Research Support Escherichia coli that produces extended-spectrum beta-lactamase (ESBL) tends to be resistant to many classes of antibiotics. Spread of these multidrug-resistant strains of E. coli in the community may lead to treatment failures of common infections such a | National Institutes of Health | 9/11/2009 |
UNIVERSITY OF PITTSBURGH THE | $165,353 |
Trans-NIH Recovery Act Research Support Sickle cell anemia is a devastating disease affecting primarily African Americans. Our goals are to capture the genetic diversity that is likely to underlie the notoriously heterogeneous clinical course of this disease, and with this information, develop
This spending item is part of a $2,981,256 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
UNIVERSITY OF PITTSBURGH THE | $164,869 | Trans-NIH Recovery Act Research Support In the proposed additional study, we intend to examine with objective measures inhibitory control and working memory in older children and adolescents adopted from the socially-emotionally depriving orphanages described above. These more specific neurocog | National Institutes of Health | 9/30/2009 |
UNIVERSITY OF PITTSBURGH THE | $164,718 | Trans-NIH Recovery Act Research Support The Rheumatoid Comparative Effectiveness Research (RACER) study offers an ideal opportunity for training in cost and comparative effectiveness (CCE) research. This RC2 supplement to the RACER parent grant 1RC2AR058989-01 will support the development of a | National Institutes of Health | 5/30/2010 |
UNIVERSITY OF PITTSBURGH THE | $164,485 |
Trans-NIH Recovery Act Research Support Rheumatoid arthritis (RA) is the most common type of inflammatory arthritis; while there are now many effective medications to treat it, these drugs vary greatly in cost (up to $15,000/year) and side effects and there is no way to predict which drug is be
This spending item is part of a $3,344,252 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
UNIVERSITY OF PITTSBURGH THE | $160,000 | Trans-NIH Recovery Act Research Support The purpose of this supplement is to integrate musculoskeletal modeling techniques with the existing study design for evaluating alterations in dynamic knee function after ACL injury/reconstruction. By combining our high-accuracy kinematic data with dyna | National Institutes of Health | 9/18/2009 |
UNIVERSITY OF PITTSBURGH THE | $158,035 | Trans-NIH Recovery Act Research Support Specific Aim 1: Provide advanced training in CER methods through a new program offered at the University of Pittsburgh. The Research Education and Career Development Core of the CTSI and ICRE currently support extensive educational programs in the basic m | National Institutes of Health | 9/23/2010 |
UNIVERSITY OF PITTSBURGH THE | $158,035 | Trans-NIH Recovery Act Research Support Specific Aim 1: Provide advanced training in CER methods through a new program offered at the University of Pittsburgh. The Research Education and Career Development Core of the CTSI and ICRE currently support extensive educational programs in the basic m | National Institutes of Health | 9/23/2010 |
UNIVERSITY OF PITTSBURGH THE | $157,775 | Trans-NIH Recovery Act Research Support The parent grant was funded for studies on the effects of TIM-1 ligation on T cell activation. This includes determination of the effects of TIM-1 ligands and specific antibodies on T cell cytokine production and effector development, and detailed analysi | National Institutes of Health | 9/21/2009 |
UNIVERSITY OF PITTSBURGH THE | $156,577 |
Trans-NIH Recovery Act Research Support The purpose of this award is identical to that stated in the original application: it is to preserve key positions in the Administrative Core, Primate Core, and Project II of the Specialized Centers Program in Reproduction and Infertility Research at the
This spending item is part of a $235,701 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
UNIVERSITY OF PITTSBURGH THE | $154,068 | Trans-NIH Recovery Act Research Support At Children's Hospital of Pittsburgh of UPMC (CHP), 1295 isolated liver transplants have been performed in children; 487 have been for biliary atresia, 70 for alpha-1-antitrypsin deficiency, 37 for Alagille syndrome, and 38 for progressive familial intrah | National Institutes of Health | 2/02/2010 |
CARNEGIE MELLON UNIVERSITY | $153,500 | Trans-NIH Recovery Act Research Support Sustained selective attention underlies our ability to process some parts of the environment at the exclusion of others over a period of time. Therefore, sustained selective attention is a crucially important process enabling one to process relevant infor | National Institutes of Health | 8/24/2009 |
UNIVERSITY OF PITTSBURGH THE | $151,500 | Trans-NIH Recovery Act Research Support Pulmonary hypertension (PH) is a life-threatening condition which can occur in association with many diseases, including chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF). PH occurring in isolation, with characteristic | National Institutes of Health | 5/08/2009 |
UNIVERSITY OF PITTSBURGH THE | $151,500 | Trans-NIH Recovery Act Research Support The central goals of this project are to develop reliable non-invasive methods using echocardiography to identify recovery of left ventricular (LV) function in heart failure patients supported by LV assist device (LVAD) and to develop novel bioengineering | National Institutes of Health | 7/15/2009 |
UNIVERSITY OF PITTSBURGH THE | $151,500 | Trans-NIH Recovery Act Research Support Our grant exploring the etiology and epidemiology of type 1 diabetes, first funded in November 1978, has resulted in the collection and accumulation of serum samples and frozen white cells over 30 years. This sample collection and efficient access to it, | National Institutes of Health | 4/28/2010 |
UNIVERSITY OF PITTSBURGH THE | $151,448 | Trans-NIH Recovery Act Research Support Under the aegis of the parental award R01CA108990 Multianalyte assay for early diagnosis of ovarian cancer, we have identified and validated a 4-biomarker panel that recognizes early stages (I-IIB) ovarian cancer with high sensitivity of 86% at 98% specif | National Institutes of Health | 8/31/2009 |
UNIVERSITY OF PITTSBURGH THE | $150,633 |
Trans-NIH Recovery Act Research Support The objective of the Pittsburgh Center for Kidney Research is to both reinforce and expand interactions among investigators at the University of Pittsburgh and colleagues at Mount Sinai School of Medicine who have had a longstanding history of research in
This spending item is part of a $236,839 allocation.
See details
|
National Institutes of Health | 8/10/2009 |
UNIVERSITY OF PITTSBURGH THE | $150,000 | Trans-NIH Recovery Act Research Support Pediatric Acute Liver Failure (PALF) results from excessive or maladaptive inflammation. Coupling broad clinical, inflammation biomarker (Luminex (TM)), and physiologic assessments with sophisticated mathematical modeling techniques will fundamentally alt | National Institutes of Health | 9/29/2009 |
CARNEGIE MELLON UNIVERSITY | $149,549 | METHODS IN MEDICAL IMAGE ANALYSIS: AN ITK-BASED COURSE WITH DELIVERABLE ALGORITHMS THAT EXTENDS AND EVALUATES ITK WHILE BROADENING ITS DEVLOPER BASE: The primary objective is to adapt an existing multi-university ITK-project-based course, titled G?Method | National Institutes of Health | 8/05/2010 |
UNIVERSITY OF PITTSBURGH THE | $149,520 | Trans-NIH Recovery Act Research Support Huntingtons disease (HD) is a chronic neurodegenerative disease resulting from an autosomal dominant mutation in the gene for the huntingtin protein (htt). It is unknown, however, how mutant huntingtin (mu htt) causes a stereotyped pattern of neuronal los | National Institutes of Health | 12/03/2010 |
UNIVERSITY OF PITTSBURGH THE | $149,509 |
Trans-NIH Recovery Act Research Support Either total body exposure to ionizing radiation or inhalation of radioactive particulates can result in significant radiation dose deposition to the lungs. While a number of side effects can be observed from this type of exposure, pulmonary fibrosis is
This spending item is part of a $850,335 allocation.
See details
|
National Institutes of Health | 6/14/2010 |
BLUE BELT TECHNOLOGIES, INC. | $148,302 | Trans-NIH Recovery Act Research Support Skull base surgery is technically the most demanding of all of the neurosurgical procedures because of the intertwining of the hard, thick skull and delicate neural and vascular structures. A safer quicker and more precise way to remove the bony skull bas | National Institutes of Health | 8/13/2009 |
STO-ROX NEIGHBORHOOD HEALTH COUNCIL INC | $148,128 | ARRA Health Center Integrated Services Development Initiative[g1] The Increased Demand for Services grant request focuses on two needs. The first was for an additinal R.N. and the second was for a part time social service worker. After we became a partner with the Pittsburgh Regional Health Initiatitive in the movement t... Show more | Health Resources and Services Administration | 3/27/2009 |
UNIVERSITY OF PITTSBURGH THE | $146,965 |
Trans-NIH Recovery Act Research Support Through funding from the National Institutes of Health, National Center for Research Resources Science Education Partnership Award, the Health Sciences and Technology Academy (HSTA) has built a partnership with investigators within the Clinical translatio
This spending item is part of a $226,568 allocation.
See details
|
National Institutes of Health | 9/01/2009 |
UNIVERSITY OF PITTSBURGH THE | $144,189 | The University of Pittsburgh has been awarded a contract to provide tumor types to the NCI for The Cancer Genome Atlas (TCGA) project. Specifically this award is to fund the provision of Breast ductal carcinoma (110 cases), Breast lobular carcinoma (15 c | National Institutes of Health | 1/25/2010 |
UNIVERSITY OF PITTSBURGH THE | $143,613 | Trans-NIH Recovery Act Research Support This study is aimed at developing in vivo targeted vaccine for tumor immunotherapy by testing whether Aghsp70 proteins improve DC functions and strong and sustained Ag-specific-T cell responses can be induced by the in vivo prolongation of Aghsp70-bearing | National Institutes of Health | 9/08/2009 |
ALLEGHENY, COUNTY OF | $142,705 |
ARRA - Communities Putting Prevention to Work: Chronic Disease Self-Manage In collaboration with the American Recovery and Reinvestment Act (ARRA)-funded Communities Putting Prevention to Work (CPPW) program, this ARRA funding will support the deployment of evidence-based chronic disease self-managemement programs (CDSMP) that emp... Show more
This spending item is part of a $1,000,000 allocation.
See details
|
Administration on Aging | 3/26/2010 |
UNIVERSITY OF PITTSBURGH THE | $142,410 | Trans-NIH Recovery Act Research Support The modern view of cerebral cortical function ascribes a critical role for corticothalamic feedback in enabling the cerebral cortex to dynamically regulate its own input. However, the role of corticothalamic (CT) circuitry remains a deep mystery. This is | National Institutes of Health | 9/28/2009 |
UNIVERSITY OF PITTSBURGH THE | $142,368 | Trans-NIH Recovery Act Research Support This application is to request additional funds through ARRA supplement mechanism for the grant R21AI79288. Although the study from this grant yielded significant findings (published in the Journal of Biological Chemistry vol. 85, p 17380), few questions | National Institutes of Health | 9/29/2010 |
UNIVERSITY OF PITTSBURGH THE | $139,133 |
The Systolic Blood pressure Intervention Trial, (SPRINT) contractor will conduct a multicenter, randomized clinical trial to determine whether treating systolic blood pressure to a lower goal than currently recommended, will reduce cardiovascular disease.
This spending item is part of a $2,491,798 allocation.
See details
|
National Institutes of Health | 9/24/2010 |
UNIVERSITY OF PITTSBURGH THE | $138,683 | Trans-NIH Recovery Act Research Support One of the central presumptions in molecular biology is that RNA functions mainly as an informational intermediate between the DNA sequence of a gene and the protein encoded by it. Although the principle is generally true in basal organisms, human cells c | National Institutes of Health | 8/31/2009 |
UNIVERSITY OF PITTSBURGH THE | $137,344 | Trans-NIH Recovery Act Research Support To allow the researcher to pursue independence as they investigate the hypothesis that NK cells respond to autophagic flux of the tumor microenvironment and that differences between tumors in this aspect may determine NK cell tumor homing. In addition, th | National Institutes of Health | 9/25/2009 |
UNIVERSITY OF PITTSBURGH THE | $136,350 | Trans-NIH Recovery Act Research Support The goal of this supplement activity is to identify the functional domains of PcrA that are critical for the growth and viability of Staphylococcus aureus. PcrA is an essential protein in S. aureus that is required for both cell growth and the replicatio | National Institutes of Health | 7/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $136,350 |
Trans-NIH Recovery Act Research Support Abstract this project aims to establish a Lung Cancer Mutation Consortium (LCMC) consisting of 13 institutions with a major interest in lung cancer and genomic testing of lung cancer as documented by having major NCI grants in lung cancer. The LCMC member
This spending item is part of a $4,894,665 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
UNIVERSITY OF PITTSBURGH THE | $134,338 | Trans-NIH Recovery Act Research Support The focus of this award is on generation of new knowledge that will lead to novel approaches to diseases. During growth factor-induced migration of adherent cells, which is critical to wound repair and tissue regeneration, adhesions to the underlying sub | National Institutes of Health | 2/24/2010 |
UNIVERSITY OF PITTSBURGH THE | $132,000 | Trans-NIH Recovery Act Research Support The project proposed in this supplement complements our experiments on drug development for Huntington's Disease with investigations on gene therapy. It will also accelerate the experimental agenda for drug discovery. The new strategy is to select drugs | National Institutes of Health | 3/04/2011 |
UNIVERSITY OF PITTSBURGH THE | $130,902 | Trans-NIH Recovery Act Research Support Current syndromic surveillance from clinical data is limited to monitoring chief complaints, which are only moderately sensitive to detecting syndromic cases. In our parent proposal, we are applying both foundational and applied research to improve our ab | National Institutes of Health | 9/03/2009 |
UNIVERSITY OF PITTSBURGH THE | $128,851 | The University of Pittsburgh has been awarded a contract to provide tumor types to the NCI for The Cancer Genome Atlas (TCGA) project. Specifically this award is to fund the provision of Endometrial carcinoma (70 cases), Hepatocellular carcinoma (20 case | National Institutes of Health | 4/06/2010 |
UNIVERSITY OF PITTSBURGH THE | $127,305 |
Trans-NIH Recovery Act Research Support As life expectancy in the US continues to rise, the maintenance of independence among older Americans has emerged as a major clinical and public health priority. Efficient and reliable locomotion, or the ability to move without assistance, is a fundamenta
This spending item is part of a $1,524,000 allocation.
See details
|
National Institutes of Health | 3/31/2010 |
NORTH SIDE CHRISTIAN HEALTH CENTER | $127,250 | ARRA Health Center Integrated Services Development Initiative[g1] NSCHC will use these funds to acquire and implement an CCHIT-Electronic Health Records System. eCw was selected and implemented when the project finalized in the 4th quarter 2011. | Health Resources and Services Administration | 6/25/2009 |
UNIVERSITY OF PITTSBURGH THE | $127,135 |
Trans-NIH Recovery Act Research Support Proteins play a central role in living organisms, serving, for example, as enzymes that catalyze metabolic reactions, as structural or mechanical units, and as cell signaling molecules. The field of proteomics, which entails large scale identification and
This spending item is part of a $707,564 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
ALLEGHENY, COUNTY OF | $125,981 |
ARRA - Communities Putting Prevention to Work: Chronic Disease Self-Manage In collaboration with the American Recovery and Reinvestment Act (ARRA)-funded Communities Putting Prevention to Work (CPPW) program, this ARRA funding will support the deployment of evidence-based chronic disease self-managemement programs (CDSMP) that emp... Show more
This spending item is part of a $1,000,000 allocation.
See details
|
Administration on Aging | 3/26/2010 |
UNIVERSITY OF PITTSBURGH THE | $125,250 |
Trans-NIH Recovery Act Research Support Lung cancer is the most common cause of cancer mortality in male and female patients in the US. The etiology of non-small cell lung cancer (NSCLC) is not fully defined, but new data suggest that estrogens as well as growth factors promote its progression.
This spending item is part of a $379,250 allocation.
See details
|
National Institutes of Health | 9/08/2009 |
UNIVERSITY OF PITTSBURGH THE | $124,999 | Trans-NIH Recovery Act Research Support Autosomal dominant polycystic kidney disease (ADPKD) is a major cause of disabling morbidity and is the fourth leading cause of end-stage renal failure in the world, affecting more than 500,000 Americans and millions more worldwide. CRISP I and II cohort | National Institutes of Health | 9/21/2009 |
DUQUESNE UNIVERSITY OF THE HOLY SPIRIT | $124,035 | Trans-NIH Recovery Act Research Support Fragile X mental retardation syndrome is the most common form of inherited mental retardation, affecting ~1 in 4000 males and ~ 1 in 8000 females. The syndrome is caused by the loss of a normal cellular protein, named the fragile X mental retardation prot | National Institutes of Health | 9/30/2009 |
CARNEGIE MELLON UNIVERSITY | $123,328 | Trans-NIH Recovery Act Research Support The primary goal of the parent grant is to collect high-resolution information on the distribution of proteins within mammalian cells and to link it to nucleotide and protein sequences. It builds on extensive prior work on development of protein tagging | National Institutes of Health | 1/14/2010 |
SQUIRREL HILL HEALTH CENTER | $123,095 | ARRA Health Center Integrated Services Development Initiative[g1] Grant Name: Increased Demand for Services Grant Purpose: IDS funds are being used to fund the salaries of employees who are all engaged in efforts to support the health center's increased patient volume and demand for services. Goalal: To provide greater... Show more | Health Resources and Services Administration | 3/27/2009 |
UNIVERSITY OF PITTSBURGH THE | $123,008 | The University of Pittsburgh has been awarded a contract to provide tumor types to the NCI for The Cancer Genome Atlas (TCGA) project. Specifically this award is to fund the provision of Endometrial carcinoma (70 cases), Hepatocellular carcinoma (20 case | National Institutes of Health | 5/04/2010 |
CELSENSE, INC. | $120,154 |
Trans-NIH Recovery Act Research Support In this proposal, we used advanced magnetic resonance imaging (MRI) technology to visualize the trafficking of cellular immunotherapy against colorectal cancer. Most often applied to advanced cancer, where existing therapies have limited efficacy, cellul
This spending item is part of a $976,850 allocation.
See details
|
National Institutes of Health | 5/05/2009 |
UNIVERSITY OF PITTSBURGH THE | $119,203 | Trans-NIH Recovery Act Research Support The focus during the first 10 years of funding for grant R01-DC003732 has been to define the role of the vestibular system in adjusting respiratory muscle activity during movement and changes in posture. The final year of the currently-funded grant propos | National Institutes of Health | 8/14/2009 |
UNIVERSITY OF PITTSBURGH THE | $118,921 |
Trans-NIH Recovery Act Research Support This project is one of three that compose the University of Pittsburgh Autism Center of Excellence (ACE). The Pittsburgh ACE is learning more about brain differences in autism and how individuals with autism process information. This administrative supp
This spending item is part of a $400,722 allocation.
See details
|
National Institutes of Health | 9/22/2009 |
UNIVERSITY OF PITTSBURGH THE | $117,503 | Trans-NIH Recovery Act Research Support The objective of this request is to more quickly achieve the goals of our NIDDK-funded research into Adenosine Receptor Function in Bladder Uroepithelium. The purpose of this parent grant is to test the hypothesis that adenosine, acting through uroepithe | National Institutes of Health | 9/01/2009 |
UNIVERSITY OF PITTSBURGH THE | $116,513 | ARRA Health Center Integrated Services Development Initiative[g1] The purpose of this grant is to enable community health centers and federally qualified health centers such as the Matilda Theiss Health Center (MTHC) to retain or increase staff in anticipation of an increase in demand for services duduring the economic do... Show more | Health Resources and Services Administration | 3/27/2009 |
UNIVERSITY OF PITTSBURGH THE | $115,384 |
Trans-NIH Recovery Act Research Support Nucleotide Excision Repair (NER) is a versatile DNA repair pathway involved in the removal of diverse lesions, including those formed by UV light, from DNA. The importance of NER is underscored by the fact that the cancer-prone inherited disorder xeroderm
This spending item is part of a $262,759 allocation.
See details
|
National Institutes of Health | 8/14/2009 |
UNIVERSITY OF PITTSBURGH THE | $113,625 | Trans-NIH Recovery Act Research Support The airway inflammatory milieu of patients with cystic fibrosis (CF) is replete with reactive oxygen species (ROS), nitric oxide (NO), and secondary oxides of nitrogen (NOx). Consequently, a multitude of oxidized and nitrated products are formed in protei | National Institutes of Health | 8/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $112,752 | Trans-NIH Recovery Act Research Support This is a supplementary fund to stimulate progress of the ongoing RO1 project. It includes personnel funds to accelerate research progress of both basic research and applied objectives. Chronic recording improvement is the immediate application-driven g | National Institutes of Health | 8/19/2009 |
COMMUNITY HUMAN SERVICES CORP | $112,097 |
Trans-NIH Recovery Act Research Support The 'Utilization of Principles of Community-Based Participator Research (CBPR) and Concept Mapping to Foster and Inform Community Engaged Research' project is an important initiative that will further increase awareness about the community based participa
This spending item is part of a $599,968 allocation.
See details
|
National Institutes of Health | 8/24/2009 |
UNIVERSITY OF PITTSBURGH THE | $111,883 | Trans-NIH Recovery Act Research Support It has been demonstrated by our studies, and the work of others, that prolonged in vivo or ex vivo exposure of murine myeloid dendritic cells (mDC) to rapamycin (RAPA) confers resistance to phenotypic (CD86 upregulation) and functional maturation (increa | National Institutes of Health | 9/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $109,486 | Trans-NIH Recovery Act Research Support The focus of the proposed studies is to examine the interaction and modulatory activity of EBP50 on all aspects of PTH1R cycling. To the best of our knowledge, we are the only laboratory comprehensively analyzing the regulatory effects of EBP50 on PTH1R c | National Institutes of Health | 8/20/2009 |
UNIVERSITY OF PITTSBURGH THE | $108,500 | Trans-NIH Recovery Act Research Support The purpose of the administrative supplement is to request funds to purchase a Real time Taqman instrument which will be used in studies related to the parent grant. Currently, our laboratory does not have a real time PCR machine and we are using ABI 7000 | National Institutes of Health | 7/29/2010 |
UNIVERSITY OF PITTSBURGH THE | $108,109 | Trans-NIH Recovery Act Research Support The Administrative Supplement to Look AHEAD will increase the scientific impact of Look AHEAD and retain and/or create new staff positions. Look AHEAD is a randomized, controlled, multi-center clinical trial comparing the long-term health effects of an in | National Institutes of Health | 9/28/2009 |
UNIVERSITY OF PITTSBURGH THE | $108,000 | Trans-NIH Recovery Act Research Support The overarching goal of the parent K23 award is to develop and pilot test a complex behavioral intervention to improve surrogate decision making for critically ill elders. The ARRA supplement award allows us to hire a study interventionist with a broader | National Institutes of Health | 4/12/2010 |
UNIVERSITY OF PITTSBURGH THE | $107,998 | Trans-NIH Recovery Act Research Support The purpose of this project is to hire an additional research assistant to enhance the goals of a career development award entitled Media Literacy to Prevent Adolescent Smoking. The hired individual will assist with data collection, analyses, and manuscri | National Institutes of Health | 9/14/2009 |
UNIVERSITY OF PITTSBURGH THE | $107,961 |
Trans-NIH Recovery Act Research Support Many biomarkers are responsive to oxidative stress and modulating effects of antioxidant dietary supplements, but the disease relevance of these markers is uncertain because of the lack of known functional or mechanistic linkages. We propose that mutation
This spending item is part of a $822,249 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
UNIVERSITY OF PITTSBURGH THE | $107,020 | Trans-NIH Recovery Act Research Support The broad aim of this research plan is to investigate developmental mechanisms involved in the early diversification of motoneurons within or originating from the lumbosacral (LS) spinal cord. Specific aims call for an investigation of the roles of Hox tr | National Institutes of Health | 9/15/2009 |
UNIVERSITY OF PITTSBURGH THE | $106,665 | Trans-NIH Recovery Act Research Support Depression in the elderly is common and causes significant distress and disability. Approximately 15% of the elderly have significant depressive symptoms. It is also the 2nd leading cause of 'global disease burden', the leading predictor of poor outcome f | National Institutes of Health | 7/16/2009 |
CARNEGIE MELLON UNIVERSITY | $105,937 |
Trans-NIH Recovery Act Research Support DESCRIPTION (provided by applicant): The proposed research investigates a representation of spatial layout that serves to guide action in the absence of direct perceptual support. We call this representation a 'spatial image.' Humans can perceive surround
This spending item is part of a $602,322 allocation.
See details
|
National Institutes of Health | 7/22/2009 |
MAGEE-WOMENS HEALTH CORPORATION | $104,061 |
Trans-NIH Recovery Act Research Support We are studying the etiology of vulvodynia, a condition characterized by chronic vulvar discomfort, most often described as burning pain, occurring in the absence of relevant visible findings or a specific, clinically identifiable, neurologic disorder. Ou
This spending item is part of a $1,900,741 allocation.
See details
|
National Institutes of Health | 9/22/2009 |
UNIVERSITY OF PITTSBURGH THE | $103,734 | Trans-NIH Recovery Act Research Support We requested funds for the Bio-Rad Laboratories Bio-Plex Workstation and Software (Suspension Array) system to provide a multiplex system to facilitate simultaneous analysis of up to 100 different biomolecules (proteins, peptides or nucleic acids) in a si | National Institutes of Health | 5/21/2009 |
UNIVERSITY OF PITTSBURGH THE | $102,883 |
Trans-NIH Recovery Act Research Support Our goal is to determine the clinical, cognitive, imaging, genetic, and biochemical biomarker characteristics of the early (pre-dementia) stages of Alzheimer's disease (AD). The project builds on the NIA-funded AD Neuroimaging Initiative (ADNI1) and serve
This spending item is part of a $23,822,294 allocation.
See details
|
National Institutes of Health | 9/24/2009 |
UNIVERSITY OF PITTSBURGH THE | $102,629 | Trans-NIH Recovery Act Research Support The parent project takes a state-of-the-art computational approach to investigate protein dynamics in relation to the molecular mechanisms of general anesthesia. The project bridges the experimental and theoretical understanding of anesthetic effects on c | National Institutes of Health | 9/06/2010 |
UNIVERSITY OF PITTSBURGH THE | $102,208 |
Trans-NIH Recovery Act Research Support Following the anthrax bioterror attacks in the US in 2001, awareness of the potentially devastating effects of attack with a bioweapon led to recognition of the need to take action and prepare against possible future nefarious events. F. tularensis was pl
This spending item is part of a $1,137,892 allocation.
See details
|
National Institutes of Health | 9/21/2009 |
DUQUESNE UNIVERSITY OF THE HOLY SPIRIT | $102,094 | ARRA - Nurse Faculty Loan Program The ARRA-NFLP 2010-2011 award will allow the Duquesne University School of Nursing to fund students planning on becoming nurse faculty and entering the nursing education workforce, further alleviating the nursing faculty shortage. Funding enables these s | Health Resources and Services Administration | 6/14/2010 |
UNIVERSITY OF PITTSBURGH THE | $102,000 |
Trans-NIH Recovery Act Research Support DESCRIPTION (provided by applicant): Cognitive dysfunction in the elderly population, ranging from simple forgetfulness to a diagnosis of Alzheimer's disease, can impact one's quality of life and ability to function in daily activities. It is crucial that
This spending item is part of a $2,305,646 allocation.
See details
|
National Institutes of Health | 5/26/2010 |
UNIVERSITY OF PITTSBURGH THE | $102,000 |
Trans-NIH Recovery Act Research Support DESCRIPTION (provided by applicant): Cognitive dysfunction in the elderly population, ranging from simple forgetfulness to a diagnosis of Alzheimer's disease, can impact one's quality of life and ability to function in daily activities. It is crucial that
This spending item is part of a $2,305,646 allocation.
See details
|
National Institutes of Health | 5/26/2010 |
NORTH SIDE CHRISTIAN HEALTH CENTER | $100,785 | ARRA Health Center Integrated Services Development Initiative[g1] North Side Christian Health Center (NSCHC) retained two medical assistants and increased a .5 biller to FTE in OY1 of this grant. This was not expected to occur until OY2. However, given the pace of growth since relocating to our new w larger community hea... Show more | Health Resources and Services Administration | 3/27/2009 |
UNIVERSITY OF PITTSBURGH THE | $100,001 | Trans-NIH Recovery Act Research Support This administrative supplement will utilize recovery act funds to more quickly and completely achieve the goals of our NIDDK-funded research into Trafficking and Regulation of the Epithelial Na+ Channel. Specific Aim 1: To determine if channel endocytosi | National Institutes of Health | 12/07/2009 |
UNIVERSITY OF PITTSBURGH THE | $100,000 | Trans-NIH Recovery Act Research Support The equipment we have requested constitutes the essential components of a rig enabling the physiological and pharmacological analysis of isolated cells. At the core of this set-up is an inverted microscope that enables visualization of the cells of intere | National Institutes of Health | 12/08/2009 |
UNIVERSITY OF PITTSBURGH THE | $100,000 | Trans-NIH Recovery Act Research Support We have identified a novel intracellular signaling molecule in the beta cell, atypical protein kinase C zeta (PKC zeta) that (i) markedly increases rodent and human basal beta cell proliferation; and, (ii) is responsible for glucose-mediated beta cell pr | National Institutes of Health | 2/01/2010 |
UNIVERSITY OF PITTSBURGH THE | $100,000 | Trans-NIH Recovery Act Research Support In previous work, we have developed, deployed and evaluated a novel intelligent medical training system for pathologic diagnosis and reporting. SlideTutor is an individualized, adaptive, simulation environment that provides explanations and assistance spe | National Institutes of Health | 7/15/2010 |
UNIVERSITY OF PITTSBURGH THE | $100,000 | Trans-NIH Recovery Act Research Support This grant is an AARA administrative supplement to parent grant U01-DE018903, titled Dental Caries: Whole Genome Association and Gene x Environment Studies. The purpose of the parent grant is to perform genome-wide association analyses of dental caries t | National Institutes of Health | 3/08/2010 |
FRED ROGERS COMPANY, THE | $99,968 |
ARRA Child Care and Development Block Grant 1.) To assist those most impacted by the recession through the provision of funds to expand services to additional children and families facing difficult economic circumstances. 2.) To provide targeted funding for investments to improve the quality of c
This spending item is part of a $13,047,215 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
UNIVERSITY OF PITTSBURGH THE | $99,940 | Trans-NIH Recovery Act Research Support Addition of a post-doctoral fellow to expedite research in specific areas of the proposal: Based on our preliminary findings (see below) that PTHrP improves beta cell survival against cytokine-mediated cell death (SA1) and that PTH1R KO mice have an impai | National Institutes of Health | 12/30/2009 |
UNIVERSITY OF PITTSBURGH THE | $99,884 | Trans-NIH Recovery Act Research Support Abnormal glomerular cell-extracellular matrix (ECM) adhesion, cytoskeleton organization and apoptosis are key factors in progressive glomerular failure. The goal of the parent project is to elucidate the molecular mechanisms by which glomerular cells con | National Institutes of Health | 8/31/2009 |
CARNEGIE MELLON UNIVERSITY | $99,865 | Trans-NIH Recovery Act Research Support The transition from adolescence to early adulthood is a neglected area of research, despite the high prevalence of risk behaviors that emerge and the potential for these risk behaviors to set in motion a pattern of behavior that will persist throughout ad | National Institutes of Health | 3/12/2010 |
UNIVERSITY OF PITTSBURGH THE | $99,452 | Trans-NIH Recovery Act Research Support The sorting and delivery of a subset of newly synthesized proteins to the apical surface is critical for maintaining renal function. This supplement focuses on the mechanisms by which apical membrane and secreted proteins are recognized and sorted. Both | National Institutes of Health | 1/01/2010 |
UNIVERSITY OF PITTSBURGH THE | $98,877 | Trans-NIH Recovery Act Research Support According to the NIH State of the Science consensus statement, the three most frequently reported and under treated cancer-related symptoms are pain, fatigue, and depression As part of a Mentored Career Development Award (K07CA118576-01), we have design | National Institutes of Health | 9/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $98,850 | Trans-NIH Recovery Act Research Support The initial phase of the North American Pancreatitis Study 2 (NAPS2) was a 20-site, multicenter molecular epidemiology study designed to determine the regional prevalence of major pancreatic diseases; to determine the underlying genetic variations and imm | National Institutes of Health | 9/28/2009 |
UNIVERSITY OF PITTSBURGH THE | $96,874 | Trans-NIH Recovery Act Research Support This project examines the clinical applicability, efficacy, and mechanisms of protective effects of low dose carbon monoxide (CO) in ameliorating liver damage due to transplant preservation injury. Cold preservation associated ischemia/reperfusion (I/R) | National Institutes of Health | 2/01/2010 |
UNIVERSITY OF PITTSBURGH THE | $94,338 | Trans-NIH Recovery Act Research Support Through our parent grant R01 DK066266 we have collected nearly 10 years of prospective post-transplant data on detailed alcohol and tobacco use in a cohort of 208 patients transplanted for alcoholic liver disease. The primary aims of the parent grant ar | National Institutes of Health | 3/09/2010 |
UNIVERSITY OF PITTSBURGH THE | $93,173 | Trans-NIH Recovery Act Research Support This competitive revision application to grant R01AG029546 is submitted in response to NOT-OD-09-058: NIH Announces the Availability of Recovery Act Funds for Competitive Revision Applications. This revision proposes to add optical brain imaging to our on | National Institutes of Health | 9/21/2009 |
CARNEGIE MELLON UNIVERSITY | $92,824 | Trans-NIH Recovery Act Research Support Biofilm formation has a major impact on human health as the underling cause of medical device-associated infection, which causes systemic infections that often prove fatal. Our study focuses on C. albicans and C. parapsilosis, which are the major contribu | National Institutes of Health | 8/01/2009 |
UNIVERSITY OF PITTSBURGH THE | $92,413 |
Trans-NIH Recovery Act Research Support This is a supplement to fund additional laboratory analyses and activity monitors to maximize the number of follow-up assessments completed in the Longitudinal Assessment of Bariatric Surgery (LABS) consortium. It will help to identify people at risk of
This spending item is part of a $772,541 allocation.
See details
|
National Institutes of Health | 3/08/2010 |
UNIVERSITY OF PITTSBURGH THE | $92,319 | Trans-NIH Recovery Act Research Support The purpose of this project is to study Benzene-induced leukemogenesis and its prevention. These studies are predicated on the following knowledge: 1) benzene-induced acute myelogenous leukemia (AML) displays MLL gene translocations; 2) benzene leukemo | National Institutes of Health | 9/18/2009 |
UNIVERSITY OF PITTSBURGH THE | $92,001 | Trans-NIH Recovery Act Research Support The Nikon Swept Field Confocal microscope system will provide widefield microscope capacity with greater speed and higher resolution than other available systems. This means that we will be able to capture the most rapid processes in delineating disease | National Institutes of Health | 2/16/2010 |
UNIVERSITY OF PITTSBURGH THE | $91,674 | Trans-NIH Recovery Act Research Support Damage to the spinal cord at suprasacral levels blocks voluntary voiding and initially produces complete urinary retention. However within a few weeks to several months after injury reflex bladder activity emerges which promotes partial recovery of lower | National Institutes of Health | 9/24/2009 |
CARNEGIE MELLON UNIVERSITY | $91,243 |
Trans-NIH Recovery Act Research Support Regenerative medicine approaches for the reconstitution of missing or injured tissues and organs involves the use of scaffolds, cells, and bioactive molecules. The use of biologic scaffolds seeded with cells is a common approach and several applications
This spending item is part of a $956,840 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
UNIVERSITY OF PITTSBURGH THE | $91,163 | Trans-NIH Recovery Act Research Support Our team developed a theory-based 'Reproductive-health Education and Awareness of Diabetes in Youth for Girls' (READY-Girls) program tailored specifically for teen women with T1D as a CD and book. This Supplement will provide funding for a student to work | National Institutes of Health | 9/29/2009 |
UNIVERSITY OF PITTSBURGH THE | $90,855 | Trans-NIH Recovery Act Research Support The goal of this supplement to my KO1 award is to support my career goals of becoming a successful independent investigator with expertise on alcohol-induced changes in the immune system, developing a well-funded laboratory and training future alcohol res | National Institutes of Health | 7/15/2009 |
UNIVERSITY OF PITTSBURGH THE | $90,764 | Trans-NIH Recovery Act Research Support Trauma is the leading cause of death and disability in children. This project will design and test neuroprotective efficacy of mitochondria targeted antioxidants against neuronal death in TBI using state of art oxidative lipidomics and mass spectrometry i | National Institutes of Health | 9/17/2009 |
ALLEGHENY-SINGER RESEARCH INSTITUTE | $89,879 |
Trans-NIH Recovery Act Research Support Our primary objective is to identify specific gene variants that are related to the formation and rupture of intracranial aneurysms (IA). Our experienced collaborative and highly productive team of Familial Intracranial Aneurysm (FIA) Investigators at 27
This spending item is part of a $8,081,413 allocation.
See details
|
National Institutes of Health | 9/14/2009 |
UNIVERSITY OF PITTSBURGH THE | $89,758 | Trans-NIH Recovery Act Research Support In the parent grant, we hypothesized that pro-oxidant pesticides inducing similar clinical manifestations - rotenone and paraquat - will have different initial sites of action. Therefore, in the precocious phases of intoxication, they will cause oxidation | National Institutes of Health | 8/12/2009 |
UNIVERSITY OF PITTSBURGH THE | $88,967 | ARRA - Scholarships for Disadvantaged Students The Scholarships for Disadvantaged Students (SDS) program promotes diversity among health profession students (including dental medicine school students) by providing scholarships to full-time students from disadvantaged backgrounds with financial need w wh... Show more | Health Resources and Services Administration | 6/14/2010 |
UNIVERSITY OF PITTSBURGH THE | $88,777 |
Trans-NIH Recovery Act Research Support ARRA - Clinical Study of Vesicoureteral Reflux in Children. This project has two primary objectives related to the on-going RIVUR trial. One objective is to develop a centralized medical image data management system for use in the RIVUR study. The seco
This spending item is part of a $361,821 allocation.
See details
|
National Institutes of Health | 8/21/2009 |
CARNEGIE MELLON UNIVERSITY | $88,700 | Trans-NIH Recovery Act Research Support This supplement requested funds to purchase optical components including a scan head and fiber coupler for an existing microscope to allow rapid, multisite computer-controlled delivery of 355 nm ultraviolet laser light for photolysis of caged glutamate. T | National Institutes of Health | 7/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $88,575 | Trans-NIH Recovery Act Research Support One of the major goals of the parent grant is to study the effect of synaptic plasticity in the output of the dorsal cochlear nucleus. The parent grant is solely based on classic electrophysiological single and paired recordings. An ideal approach to work | National Institutes of Health | 7/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $88,250 | Trans-NIH Recovery Act Research Support The University of Pittsburgh GRCs study subject recruitment efforts to date have been largely focused on the clinical practice of a single, full-time, IBD clinician in the Digestive Disorders Center at the University of Pittsburgh Medical Center (UPMC) Pr | National Institutes of Health | 9/29/2009 |
UNIVERSITY OF PITTSBURGH THE | $88,110 |
Trans-NIH Recovery Act Research Support The development of dentition involves a complex series of epithelial-mesenchymal signaling interactions. It is not surprising that such a process is prone to disturbances which then manifest as congenital tooth agenesis in up to 10% of the population and
This spending item is part of a $362,874 allocation.
See details
|
National Institutes of Health | 9/01/2009 |
UNIVERSITY OF PITTSBURGH THE | $87,028 |
Trans-NIH Recovery Act Research Support The objective of this predoctoral training program is to train the next generation of behavioral science researchers to skillfully incorporate neuroscience perspectives and methods into their programs of research, based on an understanding of brain struct
This spending item is part of a $174,056 allocation.
See details
|
National Institutes of Health | 8/13/2009 |
CARNEGIE MELLON UNIVERSITY | $87,028 |
Trans-NIH Recovery Act Research Support The objective of this predoctoral training program is to train the next generation of behavioral science researchers to skillfully incorporate neuroscience perspectives and methods into their programs of research, based on an understanding of brain struct
This spending item is part of a $174,056 allocation.
See details
|
National Institutes of Health | 8/13/2009 |
UNIVERSITY OF PITTSBURGH THE | $86,635 |
Trans-NIH Recovery Act Research Support Heart disease continues to be the leading cause of death in the United States and is associated with a variety of clinical abnormalities, including congestive heart failure, ventricular remodeling, ischemia, ion homeostasis, arrhythmias, and sudden cardia
This spending item is part of a $1,106,413 allocation.
See details
|
National Institutes of Health | 6/04/2009 |
UNIVERSITY OF PITTSBURGH THE | $84,840 | Trans-NIH Recovery Act Research Support This is a Research Supplement to Promote Diversity in Health-Related Research Program for Marcela Castillo-Rama. It has been demonstrated by our studies, and the work of others, that prolonged in vivo or ex vivo exposure of murine myeloid dendritic cells | National Institutes of Health | 9/07/2010 |
UNIVERSITY OF PITTSBURGH THE | $82,333 | Trans-NIH Recovery Act Research Support Our current R21 grant, issued by NCCAM, Acupuncture for the Treatment of Insomnia - A Pilot Study, is investigating the potential benefit of acupuncture for individuals with chronic insomnia. This supplementary award will allow the study team to assess su | National Institutes of Health | 9/16/2009 |
UNIVERSITY OF PITTSBURGH THE | $82,158 | Trans-NIH Recovery Act Research Support This administrative supplement request will serve the following specific objectives: 1) To hire a data manager/analyst. This will significantly enhance the activities of my parent R01 by increasing the capacity for data analysis. Over the last 4 years I h | National Institutes of Health | 9/29/2009 |
UNIVERSITY OF PITTSBURGH THE | $81,405 | Trans-NIH Recovery Act Research Support We have discovered that a novel protein, follistatin-like-1 (FSTL-1), is highly over-expressed in the joints of mice and humans with arthritis, especially at the interface of synovial pannus and eroding bone. A key role for FSTL-1 in arthritis progression | National Institutes of Health | 9/29/2010 |
UNIVERSITY OF PITTSBURGH THE | $80,435 | ARRA - Nurse Faculty Loan Program The purpose of the Nurse Faculty Loan Program (NFLP) proposal is to increase the number of qualified nursing faculty by providing loans to nursing students. The University of Pittsburgh School of Nursing enrolls students into Nursing Education Graduate Pr | Health Resources and Services Administration | 8/10/2009 |
UNIVERSITY OF PITTSBURGH THE | $80,234 | Trans-NIH Recovery Act Research Support This is a proposal for a summer research program for undergraduate students utilizing an administrative supplement for recovery act funds (NOT-OD-09-060) for the parent grant entitled: 'High Throughput Genetic and Drug Screens for Alpha-1-Antitrypsin Defi | National Institutes of Health | 7/15/2009 |
MAGEE-WOMENS HEALTH CORPORATION | $79,124 |
Trans-NIH Recovery Act Research Support The purpose of this award is identical to that stated in the original application: it is to preserve key positions in the Administrative Core, Primate Core, and Project II of the Specialized Centers Program in Reproduction and Infertility Research at the
This spending item is part of a $235,701 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
Mon Valley Education Consortium | $78,240 |
ARRA - Head Start Award Title: Head Start ARRA COLA Quality Improvement Training.The Grantee, University of Pittsburgh Office of Child Development (OCD), was awarded Quality Improvement funds of $91,871 More than 50% of these funds will improve staff qualifications and a
This spending item is part of a $133,250 allocation.
See details
|
Administration for Children and Families | 5/28/2009 |
FISHER SCIENTIFIC COMPANY L.L.C. | $78,142 | Laboratory Equipment and Supplies in Support of National Institute of Health ARRA Projects: This requirement will purchase laboratory supplies and equipment. The deliverables include: FLSK 175CM2 STRNK PE CAP 32/CS, PLT PST 96WL U-BTM.33ML 50/CS, PLT 96-W | National Institutes of Health | 9/21/2010 |
FISHER SCIENTIFIC COMPANY L.L.C. | $78,142 | Laboratory Equipment and Supplies. | National Institutes of Health | 9/21/2010 |
UNIVERSITY OF PITTSBURGH THE | $78,000 |
Trans-NIH Recovery Act Research Support The proposed work will establish national networking of scientists by providing a new software system (VIVO) and support for scientists using VIVO. Scientists using VIVO will be able to find other scientists and their work. Conversely, scientists using
This spending item is part of a $12,201,380 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
FISHER SCIENTIFIC COMPANY L.L.C. | $75,849 | Laboratory Equipment and supplies | National Institutes of Health | 5/17/2010 |
UNIVERSITY OF PITTSBURGH THE | $75,698 |
Trans-NIH Recovery Act Research Support The long-term objective of our research is to augment the efficacy of the cancer treatment photodynamic thearpy (PDT). Three specific aims will test the hypothesis: 1) to demonstrate that cell killing after PDT requires a definitive, enzyme-controlled, S
This spending item is part of a $490,704 allocation.
See details
|
National Institutes of Health | 7/16/2009 |
FISHER SCIENTIFIC COMPANY L.L.C. | $74,246 | Laboratory Equipment and Supplies. | Food and Drug Administration | 6/21/2010 |
UNIVERSITY OF PITTSBURGH THE | $74,184 |
Trans-NIH Recovery Act Research Support Our approach in elucidating critical pathways involved in the pathogenesis of human COPD has been to identify candidate genes from a comprehensive study of regulated genes in human lung tissues of individuals with COPD. We performed comprehensive gene exp
This spending item is part of a $1,034,638 allocation.
See details
|
National Institutes of Health | 5/30/2009 |
UNIVERSITY OF PITTSBURGH THE | $74,184 |
Trans-NIH Recovery Act Research Support Pathological cell death occurs in the course of Huntington'sdisease (HD), Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis (ALS) and also after acute brain trauma and cerebral ischemia. Drugs that inhibit caspases (enzymes that
This spending item is part of a $203,976 allocation.
See details
|
National Institutes of Health | 9/15/2009 |
UNIVERSITY OF PITTSBURGH THE | $73,922 | ARRA - Scholarships for Disadvantaged Students The University of Pittsburgh School of Nursing, started in 1939, subscribes to the Universitys commitment to teaching, research, and service. Through these major functions, the school strives to prepare nursing students who will in turn are expected to o h... Show more | Health Resources and Services Administration | 6/14/2010 |
DUQUESNE UNIVERSITY OF THE HOLY SPIRIT | $71,980 | ARRA - Nurse Faculty Loan Program The ARRA-NFLP funding has provided funding to five doctoral students planning to become nurse faculty who are entering the nursing education workforce and thus further alleviating the nursing faculty shortage. Funding enables these students to stay on tr | Health Resources and Services Administration | 8/10/2009 |
UNIVERSITY OF PITTSBURGH THE | $71,600 | Trans-NIH Recovery Act Research Support Additional equipment acquisition to further advance the research in understanding the role of Kruppel-like zinc-finger transcription factors KLF4 and KLF5, two of the most abundant transcription factors in the mouse cornea, in regulating the normal develo | National Institutes of Health | 7/22/2009 |
NSABP FOUNDATION, INC. | $69,847 | Trans-NIH Recovery Act Research Support The American Cancer Society estimated that in 2004, breast or colorectal cancer would strike over 350,000 Americans and close to 100,000 people would die from these diseases. The National Surgical Adjuvant Breast and Bowel Project(NSABP) is a multi-center | National Institutes of Health | 9/17/2009 |
Magee-Womens Research Institute and Foundation | $69,436 |
Trans-NIH Recovery Act Research Support This proposal is submitted in response to RFA-DK-06-501 for continuation of the Urinary Incontinence Treatment Network (UITN) Clinical Center at University of Maryland Baltimore (UMB). Phase II will focus on conduct of the Trial of Mid-Urethral Slings (TO
This spending item is part of a $190,000 allocation.
See details
|
National Institutes of Health | 9/30/2010 |
UNIVERSITY OF PITTSBURGH THE | $69,420 | Trans-NIH Recovery Act Research Support Aims: 1.) Examine how emotional state influences surrogates decisions to use Iife-sustaining treatments for patients; 2) Examine the mechanism whereby physician communication influences surrogates decisions to use life-sustaining treatments for patients | National Institutes of Health | 9/29/2010 |
UNIVERSITY OF PITTSBURGH THE | $68,540 | Trans-NIH Recovery Act Research Support Specific Aim to the supplement: To determine pathological and innate immune responses to various isolates of H1N1 variant viral challenges. We will establish the baseline innate immune response and pathology in ferrets to H1N1 influenza infection using | National Institutes of Health | 9/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $68,500 |
Technical support and administrative/management services: Task Order 6, Antiviral and Immune Plasma Infrastructure Development
This spending item is part of a $12,962,657 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
UNIVERSITY OF PITTSBURGH THE | $67,580 | Trans-NIH Recovery Act Research Support This award provides funds to enable us to purchase equipment that is critical to our studies on the underlying mechanism of dental pain. A critical component of these studies is establishing a causal link between changes in voltage-gated Na+ channel subu | National Institutes of Health | 9/22/2009 |
DUQUESNE UNIVERSITY OF THE HOLY SPIRIT | $66,720 |
Trans-NIH Recovery Act Research Support This project is one of three that compose the University of Pittsburgh Autism Center of Excellence (ACE). The Pittsburgh ACE is learning more about brain differences in autism and how individuals with autism process information. This administrative supp
This spending item is part of a $400,722 allocation.
See details
|
National Institutes of Health | 9/22/2009 |
COMMUNITY COLLEGE OF ALLEGHENY COUNTY | $66,275 | ARRA - Scholarships for Disadvantaged Students The Community College of Allegheny County's (CCAC) ARRA Scholarships for Disadvantaged Students In Nursing has the goal to provide funding to students enrolled in CCAC's nursing program who are economically disadvantaged. Through this grant program, disisa... Show more | Health Resources and Services Administration | 6/14/2010 |
UNIVERSITY OF PITTSBURGH THE | $63,300 | Trans-NIH Recovery Act Research Support This award allows us purchase a needed new apheresis machine (to replace existing outdated equipment) together with a service contract. The machine will be dedicated for use by the PI and co-investigators on the parent U01 and by other non-human primate t | National Institutes of Health | 9/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $62,880 |
Trans-NIH Recovery Act Research Support The long-term objective of our research is to augment the efficacy of the cancer treatment photodynamic thearpy (PDT). Three specific aims will test the hypothesis: 1) to demonstrate that cell killing after PDT requires a definitive, enzyme-controlled, S
This spending item is part of a $490,704 allocation.
See details
|
National Institutes of Health | 7/16/2009 |
UNIVERSITY OF PITTSBURGH THE | $62,880 |
Trans-NIH Recovery Act Research Support The long-term objective of our research is to augment the efficacy of the cancer treatment photodynamic thearpy (PDT). Three specific aims will test the hypothesis: 1) to demonstrate that cell killing after PDT requires a definitive, enzyme-controlled, S
This spending item is part of a $490,704 allocation.
See details
|
National Institutes of Health | 7/16/2009 |
MAGEE-WOMENS HEALTH CORPORATION | $60,000 | Trans-NIH Recovery Act Research Support Abstract Spermatogonial stem cells (SSCs) are at the foundation of mammalian spermatogenesis. In rodents, the SSC pool is comprised of type Asingle (As) spermatogonia that balance self-renewing and differentiating divisions to exactly meet the biological | National Institutes of Health | 7/29/2010 |
UNIVERSITY OF PITTSBURGH THE | $59,237 |
Trans-NIH Recovery Act Research Support This application addresses the broad Challenge Area (05) Comparative Effectiveness Research and specific Challenge Topic, 05-GM-101: Anesthesiology Clinical Pharmacology Sepsis Trauma, Burn, and Peri-operative Injury Wound Healing. Traumatic brain injury
This spending item is part of a $980,750 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
UNIVERSITY OF PITTSBURGH THE | $59,217 |
Trans-NIH Recovery Act Research Support Food allergy (FA), a condition caused by an immunoglobulin (Ig) E-mediated hypersensitivity reaction to food, is a growing clinical and public health problem in the U.S. and worldwide. FA affects approximately 5-8% children and 1-4% of adults. A positiv
This spending item is part of a $1,342,900 allocation.
See details
|
National Institutes of Health | 5/21/2009 |
CARNEGIE MELLON UNIVERSITY | $57,803 | Trans-NIH Recovery Act Research Support The ultimate goal of our research supported by R01GM084614 (?Biophysical & Molecular Biological Studies of Hemoglobin?) is to provide a detailed structural and dynamic description of how O2 binding to one subunit of the hemoglobin (Hb) molecule can alter | National Institutes of Health | 9/24/2009 |
UNIVERSITY OF PITTSBURGH THE | $57,567 | ARRA - Nurse Faculty Loan Program The purpose of the Nurse Faculty Loan Program (NFLP) is to increase the number of qualified nursing faculty by providing loans to nursing students. The University of Pittsburgh School of Nursing enrolls students in the following graduate programs: Masters | Health Resources and Services Administration | 6/14/2010 |
PITTSBURGH REGIONAL HEALTHCARE INITIATIVE | $56,970 |
ARRA - Health Information Technology Extension Program This program provides grants for the establishment of Health Information Technology Regional Extension Centers that will offer technical assistance, guidance and information on best practices to support and accelerate health care providersG?? efffforts to b... Show more
This spending item is part of a $16,545,159 allocation.
See details
|
Health and Human Services, Department of | 3/31/2010 |
Heavenlycare Daycare & Educational Center | $56,055 |
ARRA Child Care and Development Block Grant The American Recovery and Reinvestment Act (ARRA) Child Care and Development Fund (CCDF) funds have two mandatory earmarks, Infant/Toddler and Quality. The Infant/Toddler funds are utilized for new center-based Keystone Babies programs. Specifically, th
This spending item is part of a $60,146,767 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
UNIVERSITY OF PITTSBURGH THE | $55,385 | Trans-NIH Recovery Act Research Support This award is supplemental funding to enable the maintenance of a colony of musk shrews that are used in nausea/emesis research. Musk shrews (mouse-sized animals) are used for this line of work because common laboratory animals, including mice and rats, | National Institutes of Health | 9/23/2009 |
UNIVERSITY OF PITTSBURGH THE | $55,245 | Trans-NIH Recovery Act Research Support Estradiol has been shown to enhance basal forebrain cholinergic function and cognitive performance, but the mechanism by which estradiol exerts these effects is unknown. GPR30 is a novel estrogen receptor that is expressed in the brain and other tissues, | National Institutes of Health | 7/21/2009 |
CARNEGIE MELLON UNIVERSITY | $55,192 | Trans-NIH Recovery Act Research Support Our primary goals are to assess the influence of the social environment on susceptibility to upper respiratory illness and to identify the pathways through which environmental factors get under the skin to influence disease expression. We hypothesize that | National Institutes of Health | 8/16/2010 |
UNIVERSITY OF PITTSBURGH THE | $55,010 |
ARRA - Head Start Award Title: Head Start ARRA COLA Quality Improvement Training.The Grantee, University of Pittsburgh Office of Child Development (OCD), was awarded Quality Improvement funds of $91,871 More than 50% of these funds will improve staff qualifications and a
This spending item is part of a $133,250 allocation.
See details
|
Administration for Children and Families | 5/28/2009 |
Bunting, Inc. | $54,950 |
Construction Manager as Constructor at Risk services to renovation Building 10, F Wing in two phases: Phase A of the F Wing Renovation: Pre construction, construction, activation/occupancy and closeout; to convert 64,000 gsf of former patient care units o
This spending item is part of a $131,640,100 allocation.
See details
|
National Institutes of Health | 7/30/2010 |
UNIVERSITY OF PITTSBURGH THE | $51,930 | ARRA - Public Health Traineeship Program The Graduate School of Public Health at the University of Pittsburgh has applied for Public Health Service Traineeship funding to support its efforts to recruit, retain, and graduate more majority and underrepresented minority students in the nationally t | Health Resources and Services Administration | 9/03/2009 |
UNIVERSITY OF PITTSBURGH THE | $51,109 | Trans-NIH Recovery Act Research Support The award is to accelerate data acquisition related to the activities of the K99 award listed above. To this end, new equipment will be purchased to triple the available electrophysiological equipment from 3 to 9 chambers to accelerate the pace of researc | National Institutes of Health | 12/16/2009 |
UNIVERSITY OF PITTSBURGH THE | $50,798 | Trans-NIH Recovery Act Research Support The overarching goal of this project is to accelerate the dissemination of findings from the SMART Trial. Funding was requested to hire a statistician to contribute a significant level of effort to this project. At this time data are available for the 6 m | National Institutes of Health | 1/12/2010 |
UNIVERSITY OF PITTSBURGH THE | $50,340 |
Trans-NIH Recovery Act Research Support Type 2 diabetes mellitus (DM2), is causally associated with coronary artery disease (CAD), and is a major health and economic burden. Despite multiple preventive and therapeutic measures implemented in the last few decades to decrease the occurrence and p
This spending item is part of a $1,160,811 allocation.
See details
|
National Institutes of Health | 8/14/2009 |
FISHER SCIENTIFIC COMPANY L.L.C. | $50,018 |
The overall purpose of the ARRA funds received by Merck is to provide the CDC Project grantees vaccines for their respective Immunization Programs. In some instances, the ARRA funds will provide vaccines that would cover a budget shortfall in the program
This spending item is part of a $32,281,289 allocation.
See details
|
Centers for Disease Control and Prevention | 8/27/2009 |
UNIVERSITY OF PITTSBURGH THE | $50,000 | Trans-NIH Recovery Act Research Support The overall goal of this research project is to identify the molecular mechanisms by which estrogen preserves bone mass in order to permit the design of better therapies for osteoporosis. Osteoporosis is a major health problem in the elderly resulting in | National Institutes of Health | 9/18/2009 |
UNIVERSITY OF PITTSBURGH THE | $50,000 | Trans-NIH Recovery Act Research Support This project is designed to characterize the binding of a relatively new inhibitor of the epithelial sodium channel (ENaC). ENaC helps facilitate Na+ transport across epithelia in the kidney where it helps regulate extracellular Na+ balance and blood pre | National Institutes of Health | 12/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $50,000 | Trans-NIH Recovery Act Research Support The purpose of this ARRA Supplement to NIAID K08 award, The role of BBI36/38 in Lyme disease pathogenesis (5K08AI072365-03), is to extend the studies which are in progress on the pathogenesis of Lyme disease. We focus on Borrelia burgdorferi, the causati | National Institutes of Health | 8/23/2010 |
UNIVERSITY OF PITTSBURGH THE | $49,992 | Trans-NIH Recovery Act Research Support As a part of the NCI-designated Cancer Center Supplement of the parent grant P30CA047904, UPCI agrees to participate in the planning activities associated with the project entitled ADOPTion of New Technologies for Remote Data Capture and Protocol Authorin | National Institutes of Health | 9/18/2009 |
UNIVERSITY OF PITTSBURGH THE | $49,306 |
Trans-NIH Recovery Act Research Support This award supports the Development of Multi-site Functional Neurocognitive and Behavioral Assessments within Children's Oncology Group (COG) to ensure Stable Measures for More Informed Phase III Clinical Trials. The Behavioral Science Committee (BSC) of
This spending item is part of a $233,108 allocation.
See details
|
National Institutes of Health | 8/28/2009 |
UNIVERSITY OF PITTSBURGH THE | $48,535 | Trans-NIH Recovery Act Research Support Craniofacial and dental genetic disorders like CL/P constitute a significant public health burden. The parent grant focuses on enhancing our understanding of such complex traits by developing, implementing computationally, and applying in analyses, statis | National Institutes of Health | 9/22/2009 |
UNIVERSITY OF PITTSBURGH THE | $48,535 | Trans-NIH Recovery Act Research Support Craniofacial and dental genetic disorders like CL/P constitute a significant public health burden. The parent grant focuses on enhancing our understanding of such complex traits by developing, implementing computationally, and applying in analyses, statis | National Institutes of Health | 9/22/2009 |
UNIVERSITY OF PITTSBURGH THE | $47,740 |
Trans-NIH Recovery Act Research Support Approximately one third of adults and up to 70% of all adolescents with severe obesity has obstructive sleep apnea (OSA). The pulmonary, cardiovascular, and cognitive consequences of this disorder are profound. Available evidence strongly supports o
This spending item is part of a $155,376 allocation.
See details
|
National Institutes of Health | 9/17/2009 |
PRIMARY PHYSICIANS RESEARCH P | $47,300 |
The contractor shall furnish all necessary facilities, equipment, materials, and personnel, and shall perform all services necessary to conduct three clincial studies entitled FUF14 - H1N1 Adult/Ederly Clinical Study; FUF15 - H1N1 Pediatric Clinical Study
This spending item is part of a $29,360,000 allocation.
See details
|
Office of Assistant Secretary for Administration and Management | 9/30/2009 |
PRIMARY PHYSICIANS RESEARCH P | $47,300 |
The contractor shall furnish all necessary facilities, equipment, materials, and personnel, and shall perform all services necessary to conduct three clincial studies entitled FUF14 - H1N1 Adult/Ederly Clinical Study; FUF15 - H1N1 Pediatric Clinical Study
This spending item is part of a $29,360,000 allocation.
See details
|
Office of Assistant Secretary for Administration and Management | 9/30/2009 |
CHATHAM UNIVERSITY | $45,441 | ARRA - Scholarships for Disadvantaged Students The grant name is: ARRA Scholarships for Disadvantaged Students. The purpose of this project is to award scholarships to students in Chatham's Physician Assistant and Nursing programs who are economically disadvantaged. The awarding of such scholarships s t... Show more | Health Resources and Services Administration | 6/16/2010 |
UNIVERSITY OF PITTSBURGH THE | $44,900 | Trans-NIH Recovery Act Research Support The purpose of this supplement is to buy an Isokinetic Dynamometer that will be used during implementation of the research proposed for the parent grant (Neuromuscular Electrical Stimulation in Individuals with Rheumatoid Arthritis- 1 KOI HD 058035 - 01 A | National Institutes of Health | 1/27/2010 |
FISHER SCIENTIFIC COMPANY L.L.C. | $44,615 | Laboratory Equipment and Supplies in Support of National Institute of Health ARRA Projects: This requirement will purchase laboratory supplies and equipment. The deliverables include: WIPERS WYPALL L10 YTIL125/PK, 10% BUFFERED FORMALIN CR 4L, FLASK FILTE | National Institutes of Health | 9/21/2010 |
NETWORK FOR REGIONAL HEALTHCARE IMPROVEMENT | $44,280 |
BAH will provide technical assistance to the Beacon Community Cooperative Agreement awardees and ONC as together they lead the development of a regional healthcare strategy for Health Information Technology (HIT) ?enabled cost and quality performance impr
This spending item is part of a $11,933,252 allocation.
See details
|
Program Support Center | 9/30/2010 |
UNIVERSITY OF PITTSBURGH THE | $44,005 |
Trans-NIH Recovery Act Research Support Longitudinal Assessment of Bariatric Surgery (LABS) consortium was established in 2003 and was conceived to address important issues in bariatric surgery and metabolism in the obese and morbidly obese. LABS explores relationships of patient characteristi
This spending item is part of a $501,011 allocation.
See details
|
National Institutes of Health | 3/29/2010 |
UNIVERSITY OF PITTSBURGH THE | $42,773 |
Trans-NIH Recovery Act Research Support The recent passage of the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008, which requires private health plans to provide equal coverage of behavioral and medical/surgical services, also known as parity, represents a
This spending item is part of a $652,431 allocation.
See details
|
National Institutes of Health | 8/30/2010 |
FISHER SCIENTIFIC COMPANY L.L.C. | $42,176 |
The overall purpose of the ARRA funds received by Merck is to provide the CDC Project grantees vaccines for their respective Immunization Programs. In some instances, the ARRA funds will provide vaccines that would cover a budget shortfall in the program
This spending item is part of a $11,078,153 allocation.
See details
|
Centers for Disease Control and Prevention | 4/01/2010 |
UNIVERSITY OF PITTSBURGH THE | $41,523 |
Trans-NIH Recovery Act Research Support The candidate's main objective is to establish a vigorous, independent research program centered on structure and function studies of HIV replication complexes. The new findings will be exploited to discover novel effective antiretroviral inhibitors. Sinc
This spending item is part of a $237,195 allocation.
See details
|
National Institutes of Health | 1/24/2011 |
MAGEE-WOMENS HEALTH CORPORATION | $41,405 | Trans-NIH Recovery Act Research Support Adipose tissue development is a crucial contributor to obesity and the associated type II diabetes and Metabolic Syndrome. Much has been learned about adipogenesis in tissue culture models, but relatively little is known about its in vivo mechanisms. Our | National Institutes of Health | 12/14/2009 |
UNIVERSITY OF PITTSBURGH THE | $39,590 | Trans-NIH Recovery Act Research Support The goal of this supplement is to hire summer students or science educators for research on NIH grant award #U01AI077771 entitled Virus-Like Particle Vaccines for Pandemic Influenza. The goal of this supplement is to hire summer students or science educ | National Institutes of Health | 6/04/2009 |
UNIVERSITY OF PITTSBURGH THE | $38,164 | Trans-NIH Recovery Act Research Support This award provides funds to enable us to purchase equipment that is critical to our alcohol research program. The backbone of our alcohol research program is the production of genetically engineered (knockin and knockout) mice. Funds to purchase (A) a | National Institutes of Health | 8/12/2009 |
UNIVERSITY OF PITTSBURGH THE | $36,886 | Trans-NIH Recovery Act Research Support Neuroprotection and early detection in PD. This core provides services for our Udall center, including ordering, the management of funds, and assistance with the preparation of manuscripts and progress reports. | National Institutes of Health | 9/28/2009 |
UNIVERSITY OF PITTSBURGH THE | $36,869 |
Trans-NIH Recovery Act Research Support Traditional frequentist methods for analysis of clinical trials are generally accepted as the gold standard in research practice. Newer Bayesian methods, however, hold great promise for a more efficient analytic approach, thereby lowering the costs of cl
This spending item is part of a $937,264 allocation.
See details
|
National Institutes of Health | 9/20/2010 |
DUQUESNE UNIVERSITY OF THE HOLY SPIRIT | $36,580 | Trans-NIH Recovery Act Research Support The molybdenum cofactor (Moco) is a remarkable metal center that lies at the catalytic heart of a variety of enzymes. The unique and `universal' Moco has the same core structure in all mononuclear molybdenum enzymes (MMEs) and is found in all forms of lif | National Institutes of Health | 9/15/2009 |
UNIVERSITY OF PITTSBURGH THE | $36,500 | ARRA - Scholarships for Disadvantaged Students The Scholarships for Disadvantaged Students (SDS) program promotes diversity among health profession students (including medical school students) by providing scholarships to full-time students from disadvantaged backgrounds with financial need who are e en... Show more | Health Resources and Services Administration | 6/14/2010 |
UNIVERSITY OF PITTSBURGH THE | $36,453 | Trans-NIH Recovery Act Research Support The major piece of equipment (the bomb calorimeter) purchased under this ARRA award will be used to assess the energy content of fecal matter from mice, a critical component of energy homeostasis. The other equipment (Harvard pumps) is used to deliver r | National Institutes of Health | 2/02/2010 |
UNIVERSITY OF PITTSBURGH THE | $36,215 | ARRA - Scholarships for Disadvantaged Students The Scholarships for Disadvantaged Students (SDS) program promotes diversity among health profession students (including medical school students) by providing scholarships to full-time students from disadvantaged backgrounds with financial need who are e en... Show more | Health Resources and Services Administration | 9/03/2009 |
CARNEGIE MELLON UNIVERSITY | $34,915 |
Trans-NIH Recovery Act Research Support The work proposed for supplemental funding is directly responsive to the National Institute of Mental Health (NIMH) Strategic Plan. Specifically, our work will further develop designs for intervention studies. Our preliminary work combining claims data
This spending item is part of a $265,452 allocation.
See details
|
National Institutes of Health | 3/01/2010 |
CARNEGIE MELLON UNIVERSITY | $34,654 |
Trans-NIH Recovery Act Research Support The objective of this funded study is to develop new scientific tools to investigate the relatedness of neural, biochemical, and vascular processes in the brain. This study will develop and advance neuroimaging techniques to simultaneously measure neuron
This spending item is part of a $411,765 allocation.
See details
|
National Institutes of Health | 6/05/2009 |
UNIVERSITY OF PITTSBURGH THE | $34,084 | Trans-NIH Recovery Act Research Support This application is a supplement requesting additional support for R-01 DK 51081. Briefly, as described in the original application which received a percentile score of 4th percentile, this proposal supports a head-to-head trial of the best (and only) co | National Institutes of Health | 6/28/2010 |
UNIVERSITY OF PITTSBURGH THE | $33,809 | Trans-NIH Recovery Act Research Support The goal of this supplement is to recruit for additional needed skills. A person has been identified for this position. She will add new skills and techniques that are currently not part of this grant application. She will perform molecular biology dev | National Institutes of Health | 9/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $33,482 | Trans-NIH Recovery Act Research Support Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL) investigators propose that consistent use of a lesser donor operation will increase acceptability for both the public and medical community and increase the numbers of living donor liv | National Institutes of Health | 9/30/2010 |
UNIVERSITY OF PITTSBURGH THE | $33,404 |
To design and test a method of intervention that has the capacity to promote engagement and adherence to treatment, foster recovery and reduce or prevent disability in patients experiencing a first episode of schizophrenia and related psychotic disorders.
This spending item is part of a $16,872,951 allocation.
See details
|
National Institutes of Health | 7/13/2009 |
UNIVERSITY OF PITTSBURGH THE | $32,867 |
Trans-NIH Recovery Act Research Support Follicular development and differentiation, key to female reproduction, are sequential events that are tightly regulated by balanced cell proliferation, survival and cell death. Previously we reported the prohibitins, PHB1 and REA, as important mediators
This spending item is part of a $593,496 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
UNIVERSITY OF PITTSBURGH THE | $32,573 | Trans-NIH Recovery Act Research Support Silicosis develops many years after initial exposure to silica particles and is characterized by chronic inflammation, lung fibrosis and ultimately respiratory impairment. There is no effective treatment for silicosis. The biochemical mechanisms behind si | National Institutes of Health | 6/01/2009 |
UNIVERSITY OF PITTSBURGH THE | $32,419 |
The funds will be used for the following purposes in support of the Accelerating Clinical Trials of Novel Oncologic PathWays (ACTNOW) project: 1) acceleration of IRB approvals with additional regulatory personnel at each site; 2) additional patient naviga
This spending item is part of a $942,533 allocation.
See details
|
National Institutes of Health | 8/31/2009 |
UNIVERSITY OF PITTSBURGH THE | $32,221 |
Trans-NIH Recovery Act Research Support This proposal addresses a problem central to the study of focal ischemic stroke therapy: the blood- brain barrier (BBB) breakdown via vasogenic edema that restricts the window of tPA administration. We will study the initial BBB disruption after which the
This spending item is part of a $415,950 allocation.
See details
|
National Institutes of Health | 6/15/2009 |
UNIVERSITY OF PITTSBURGH THE | $31,917 |
Trans-NIH Recovery Act Research Support Longitudinal Assessment of Bariatric Surgery (LABS) consortium was established in 2003 and was conceived to address important issues in bariatric surgery and metabolism in the obese and morbidly obese. LABS explores relationships of patient characteristic
This spending item is part of a $299,999 allocation.
See details
|
National Institutes of Health | 3/26/2010 |
UNIVERSITY OF PITTSBURGH THE | $30,475 | ARRA - Scholarships for Disadvantaged Students The University of Pittsburgh - School of Health and Rehabilitation Sciences (SHRS) is one of the six health sciences schools in the University and is committed to the mission of advancing health and rehabilitation through research, teaching, and professisio... Show more | Health Resources and Services Administration | 6/14/2010 |
UNIVERSITY OF PITTSBURGH THE | $30,300 |
Trans-NIH Recovery Act Research Support DESCRIPTION (provided by applicant): Epithelial Na channels (ENaC) are expressed in the distal nephron where they serve as the final sites of Na reabsorption, thereby playing a key role in the regulation of extracellular fluid volume and blood pressure (B
This spending item is part of a $443,125 allocation.
See details
|
National Institutes of Health | 7/17/2009 |
UNIVERSITY OF PITTSBURGH THE | $30,000 |
Trans-NIH Recovery Act Research Support The Oroboros Oxygraph-2K that will be purchased with the supplemental funds will provide the addition of high-resolution respirometry measurements of mitochondria function in human biopsy samples obtained in the parent project.
This spending item is part of a $60,000 allocation.
See details
|
National Institutes of Health | 7/21/2009 |
UNIVERSITY OF PITTSBURGH THE | $30,000 | Trans-NIH Recovery Act Research Support Funds for the purchase of equipment, as a supplement to Chaperone Actions in CFTR Biogenesis (3R01DK068196-06), will be used to purchase a fluorescence spectrophotometer. This equipment will be used to facilitate the completion of in vitro structural stu | National Institutes of Health | 12/28/2009 |
FISHER SCIENTIFIC COMPANY L.L.C. | $28,162 | Laboratory Equipment and Supplies. | National Institutes of Health | 8/09/2010 |
UNIVERSITY OF PITTSBURGH THE | $27,486 |
Trans-NIH Recovery Act Research Support To date, one must conclude that the pace of progress in disease control and preservation of functional integrity and quality of life for pediatric brain tumors remains below that of most other major types of childhood cancers. Recent advances in cellular
This spending item is part of a $381,202 allocation.
See details
|
National Institutes of Health | 8/20/2009 |
UNIVERSITY OF PITTSBURGH THE | $27,388 |
Trans-NIH Recovery Act Research Support To date, one must conclude that the pace of progress in disease control and preservation of functional integrity and quality of life for pediatric brain tumors remains below that of most other major types of childhood cancers. Recent advances in cellular
This spending item is part of a $482,421 allocation.
See details
|
National Institutes of Health | 8/18/2009 |
UNIVERSITY OF PITTSBURGH THE | $27,388 |
Trans-NIH Recovery Act Research Support To date, one must conclude that the pace of progress in disease control and preservation of functional integrity and quality of life for pediatric brain tumors remains below that of most other major types of childhood cancers. Recent advances in cellular
This spending item is part of a $482,434 allocation.
See details
|
National Institutes of Health | 8/19/2009 |
UNIVERSITY OF PITTSBURGH THE | $26,894 | Trans-NIH Recovery Act Research Support This application aims to supplement an active K99 award (NIDCR K99 DE-018954-01, Matrix metalloproteinase gene variants and cleft lip/palate) with the purpose of adding technical personnel. The supplement would allow to promote job creation and economic d | National Institutes of Health | 9/22/2009 |
UNIVERSITY OF PITTSBURGH THE | $26,894 | Trans-NIH Recovery Act Research Support Cancer and congenital malformations occasionally may have a common etiology. We have recently demonstrated that cleft families present a higher incidence of family history of cancer and that AXIN2, a gene that when mutated increases susceptibility to colo | National Institutes of Health | 9/22/2009 |
CARNEGIE MELLON UNIVERSITY | $26,288 |
Trans-NIH Recovery Act Research Support Development of a comprehensive, easily accessible public resource database of images, videos, and animations of cells from a variety of organisms, including both cell architecture and intracellular functionalities, as well as stimulate the economy through
This spending item is part of a $2,490,729 allocation.
See details
|
National Institutes of Health | 9/30/2009 |
UNIVERSITY OF PITTSBURGH THE | $25,371 |
Trans-NIH Recovery Act Research Support This supplement award supports the Accelerating Clinical Trials of Novel Oncologic Path Ways (ACTNOW) program for Protocol ADVL0813, which is a Phase I Study of IMC-A12 (Anti-Insulin-Like Growth Factor-I Receptor Monoclonal Antibody) in Combination with C
This spending item is part of a $750,000 allocation.
See details
|
National Institutes of Health | 8/13/2009 |
UNIVERSITY OF PITTSBURGH THE | $25,000 | Trans-NIH Recovery Act Research Support $25,000 supplement to K24 to purchase research van for the transport of study patients | National Institutes of Health | 2/10/2010 |
UNIVERSITY OF PITTSBURGH THE | $25,000 |
Trans-NIH Recovery Act Research Support The overall goal of our research is to elucidate the pathogenesis of primary open-angle glaucoma (POAG) making it possible to implement effective screening and prevention strategies and to develop novel therapies. The primary aim of this proposal is to id
This spending item is part of a $503,839 allocation.
See details
|
National Institutes of Health | 6/30/2009 |
UNIVERSITY OF PITTSBURGH THE | $24,543 | The University of Pittsburgh has been awarded a contract to provide tumor types to the NCI for The Cancer Genome Atlas (TCGA) project. Specifically this award is to fund the provision of renal (10 cases), kidney papillary (3 cases), cervical (10 cases), | National Institutes of Health | 3/31/2010 |
UNIVERSITY OF PITTSBURGH THE | $23,391 |
Trans-NIH Recovery Act Research Support The prevalence of fluorosis among the population is increasing yet we currently know very little about what causes fluorosis. We have previously demonstrated that fluoride elicits a cell stress response which in turn, activates genes to help the cell cope
This spending item is part of a $1,142,778 allocation.
See details
|
National Institutes of Health | 4/29/2009 |
PRIMARY PHYSICIANS RESEARCH P | $23,292 |
The contractor shall furnish all necessary facilities, equipment, materials, and personnel, and shall perform all services necessary to conduct three clincial studies entitled FUF14 - H1N1 Adult/Ederly Clinical Study; FUF15 - H1N1 Pediatric Clinical Study
This spending item is part of a $29,360,000 allocation.
See details
|
Office of Assistant Secretary for Administration and Management | 9/30/2009 |
PRIMARY PHYSICIANS RESEARCH P | $23,291 |
The contractor shall furnish all necessary facilities, equipment, materials, and personnel, and shall perform all services necessary to conduct three clincial studies entitled FUF14 - H1N1 Adult/Ederly Clinical Study; FUF15 - H1N1 Pediatric Clinical Study
This spending item is part of a $29,360,000 allocation.
See details
|
Office of Assistant Secretary for Administration and Management | 9/30/2009 |
UNIVERSITY OF PITTSBURGH THE | $23,257 |
Trans-NIH Recovery Act Research Support This project launches a collaborative effort to advance adoption within the HMO Cancer Research Network (CRN) of G?industrial-strengthG? natural language processing (NLP) systems useful for mining valuable, research-grade information from unstructured cli
This spending item is part of a $992,334 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
UNIVERSITY OF PITTSBURGH THE | $22,849 |
Trans-NIH Recovery Act Research Support In this proposal, we used advanced magnetic resonance imaging (MRI) technology to visualize the trafficking of cellular immunotherapy against colorectal cancer. Most often applied to advanced cancer, where existing therapies have limited efficacy, cellul
This spending item is part of a $976,850 allocation.
See details
|
National Institutes of Health | 5/05/2009 |
UNIVERSITY OF PITTSBURGH THE | $22,465 |
Trans-NIH Recovery Act Research Support This supplement award supports Accelerating Clinical Trials of Novel Oncologic Path Ways (ACT NOW) program for Protocol ADVL0911, which is a Phase I Dose Escalation Study of Seneca Valley Virus (SVV-001), a Replication-Competent Picornavirus, in Relapsed/
This spending item is part of a $1,405,307 allocation.
See details
|
National Institutes of Health | 8/12/2009 |
UNIVERSITY OF PITTSBURGH THE | $21,537 |
ARRA - Early Head Start The University of Pittsburgh Office of Child Development will provide Early Head Start services to families with infant and toddlers. The model is primarily home-based with children within Allegheny County. The primary communities are the city of Clairton
This spending item is part of a $2,639,588 allocation.
See details
|
Administration for Children and Families | 11/19/2009 |
UNIVERSITY OF PITTSBURGH THE | $21,271 | Trans-NIH Recovery Act Research Support The parent grant, R01 AR051963 entitled Chondrogenesis in situ, focuses on safe, localized in vivo use of bioactive factors to improve the cartilage repair potential of adult human bone marrow cells. The goal of the administrative supplement grant R01AR05 | National Institutes of Health | 5/19/2010 |
UNIVERSITY OF PITTSBURGH THE | $18,665 | Trans-NIH Recovery Act Research Support Title: The contribution of DNA interstrand crosslinks to Aging RO1 ES016114 This is a supplement to an existing RO1 from NIEHS. The purpose of the parental project is to test the hypothesis that the cellular response to crosslinking agents is determined a | National Institutes of Health | 5/21/2010 |
UNIVERSITY OF PITTSBURGH THE | $15,729 | Trans-NIH Recovery Act Research Support Primary liver cancers are highly malignant tumors in human and their incidences are rising in the United States. The overall survival of patients with liver cancer is grim and currently no efficient chemoprevention is available. The current proposal eval | National Institutes of Health | 7/20/2009 |
ALLEGHENY-SINGER RESEARCH INSTITUTE | $15,392 | Trans-NIH Recovery Act Research Support Multimodal CT and MRI are available to study and diagnose stroke pathological progression, can rule out hemorrhagic stroke, and possibly can be used to extend the time limit for thrombolysis, but there is no way to determine the time limit after which rep | National Institutes of Health | 7/24/2009 |
UNIVERSITY OF PITTSBURGH THE | $15,367 | Trans-NIH Recovery Act Research Support This award is for the purchase of a Tetra 2 four-bay thermal cycler chasis. Many of the genes associated with orofacial clefting encode regulatory proteins that are prominent regulators of gene expression, associated with a wide variety of cellular and d | National Institutes of Health | 6/29/2010 |
FISHER SCIENTIFIC COMPANY L.L.C. | $15,252 | Laboratory Equipment and Supplies. | National Institutes of Health | 11/18/2009 |
UNIVERSITY OF PITTSBURGH THE | $15,000 |
Trans-NIH Recovery Act Research Support This application addresses broad Challenge Area (04) Clinical Research, specific Challenge Topic 04-HL-104'Perform secondary analyses of existing data to answer important clinical and preventive medicine researchquestions.' We propose to use existing data
This spending item is part of a $998,292 allocation.
See details
|
National Institutes of Health | 9/23/2009 |
FISHER SCIENTIFIC COMPANY L.L.C. | $13,406 | Laboratory Equipment and Supplies. | National Institutes of Health | 9/21/2010 |
MAGEE-WOMENS HEALTH CORPORATION | $11,139 | Trans-NIH Recovery Act Research Support This Program Project addresses among the most important questions in stem cell medicine and biology through responsible studies on the potentials of pluripotent stem cells from humans (hESC) and nonhuman primates (nhpESC) during development in vitro and i | National Institutes of Health | 7/14/2009 |
MAGEE-WOMENS HEALTH CORPORATION | $11,139 | Trans-NIH Recovery Act Research Support This Program Project addresses among the most important questions in stem cell medicine and biology through responsible studies on the potentials of pluripotent stem cells from humans (hESC) and nonhuman primates (nhpESC) during development in vitro and i | National Institutes of Health | 5/10/2010 |
MAGEE-WOMENS HEALTH CORPORATION | $11,139 | Trans-NIH Recovery Act Research Support DESCRIPTION (provided by applicant): This Program Project addresses among the most important questions in stem cell medicine and biology through responsible studies on the potentials of pluripotent stem cells from humans (hESC) and nonhuman primates (nhpE | National Institutes of Health | 5/10/2010 |
FISHER SCIENTIFIC COMPANY L.L.C. | $9,636 | Laboratory Equipment and Supplies. | National Institutes of Health | 5/17/2010 |
FISHER SCIENTIFIC COMPANY L.L.C. | $8,819 | Laboratory Equipment and supplies | National Institutes of Health | 9/22/2010 |
FISHER SCIENTIFIC COMPANY L.L.C. | $8,637 | NIH Bethesda MD - Laboratory Supplies | National Institutes of Health | 12/17/2009 |
FISHER SCIENTIFIC COMPANY L.L.C. | $8,637 | Laboratory Equipment and Supplies. | National Institutes of Health | 12/07/2009 |
UNIVERSITY OF PITTSBURGH THE | $8,000 | Trans-NIH Recovery Act Research Support Award Title: TNFalpha Control of a Surfactant Enzyme in Lung Injury Description: The purpose of this award is to fund the salary of an undergraduate student to perform summer biomedical research. Overall Purpose: The study purpose was to test if an injuri | National Institutes of Health | 8/24/2010 |
FISHER SCIENTIFIC COMPANY L.L.C. | $7,214 | Laboratory Equipment and supplies for the National Institute on Deafness and other Communication Disorders | National Institutes of Health | 1/31/2010 |
FISHER SCIENTIFIC COMPANY L.L.C. | $5,970 | NIDA/Addition Res Center, Baltimore, Marland. Refig Chromatg 45.4 CUFT 115V and a Feezer | National Institutes of Health | 2/25/2010 |
UNIVERSITY OF PITTSBURGH THE | $5,610 |
Trans-NIH Recovery Act Research Support The overall goal of the proposed research program is to design and develop a noninvasive device for accurately measuring arterial compliance. Arterial compliance has been shown to be a strong indicator of many types of vascular disease, including cardiova
This spending item is part of a $664,541 allocation.
See details
|
National Institutes of Health | 7/15/2009 |
UNIVERSITY OF PITTSBURGH THE | $5,610 |
Trans-NIH Recovery Act Research Support The overall goal of the proposed research program is to design and develop a noninvasive device for accurately measuring arterial compliance. Arterial compliance has been shown to be a strong indicator of many types of vascular disease, including cardiova
This spending item is part of a $76,467 allocation.
See details
|
National Institutes of Health | 2/02/2011 |
DUQUESNE UNIVERSITY OF THE HOLY SPIRIT | $5,429 | Trans-NIH Recovery Act Research Support Body size can be altered by pituitary growth hormone, with the largest and smallest nonobese humans varying by about 10-fold in body mass. Organ sizes generally vary with body size, although there are indicators of local organ size regulation as well. A | National Institutes of Health | 7/10/2009 |
Sodexo, Inc. | $5,000 |
ARRA - Preventing Healthcare-Associated Infections This program is intended to address the Health and Human Services Action Plan to prevent healthcare associated infections (HAI). Funding will provide for technical assistance to make critical short-term investments that will provide for a sustainablble sta... Show more
This spending item is part of a $1,020,480 allocation.
See details
|
Centers for Disease Control and Prevention | 8/28/2009 |
UPMC PASSAVANT | $5,000 |
ARRA - Preventing Healthcare-Associated Infections This program is intended to address the Health and Human Services Action Plan to prevent healthcare associated infections (HAI). Funding will provide for technical assistance to make critical short-term investments that will provide for a sustainablble sta... Show more
This spending item is part of a $1,020,480 allocation.
See details
|
Centers for Disease Control and Prevention | 8/28/2009 |
West Penn Allegheny Health System, Inc. | $5,000 |
ARRA - Preventing Healthcare-Associated Infections This program is intended to address the Health and Human Services Action Plan to prevent healthcare associated infections (HAI). Funding will provide for technical assistance to make critical short-term investments that will provide for a sustainablble sta... Show more
This spending item is part of a $1,020,480 allocation.
See details
|
Centers for Disease Control and Prevention | 8/28/2009 |
ST. CLAIR MEMORIAL HOSPITAL | $5,000 |
ARRA - Preventing Healthcare-Associated Infections This program is intended to address the Health and Human Services Action Plan to prevent healthcare associated infections (HAI). Funding will provide for technical assistance to make critical short-term investments that will provide for a sustainablble sta... Show more
This spending item is part of a $1,020,480 allocation.
See details
|
Centers for Disease Control and Prevention | 8/28/2009 |
FISHER SCIENTIFIC COMPANY L.L.C. | $4,209 | Laboratory Equipment and Supplies. | National Institutes of Health | 9/21/2010 |
FISHER SCIENTIFIC COMPANY L.L.C. | $3,000 | Laboratory Equipment and Supplies. | National Institutes of Health | 9/29/2010 |
Upmc Saint Margaret Family Health Center | $2,500 |
ARRA - Preventing Healthcare-Associated Infections This program is intended to address the Health and Human Services Action Plan to prevent healthcare associated infections (HAI). Funding will provide for technical assistance to make critical short-term investments that will provide for a sustainablble sta... Show more
This spending item is part of a $1,020,480 allocation.
See details
|
Centers for Disease Control and Prevention | 8/28/2009 |
FISHER SCIENTIFIC COMPANY L.L.C. | $436 | Laboratory & hospital supplies for New England Medical Center | National Institutes of Health | 12/15/2009 |
FISHER SCIENTIFIC COMPANY L.L.C. | $428 | New England Med CTR Hospital Laboratory Supplies | National Institutes of Health | 12/04/2009 |
FISHER SCIENTIFIC COMPANY L.L.C. | $373 | Laboratory Supplies | National Institutes of Health | 12/11/2009 |
FISHER SCIENTIFIC COMPANY L.L.C. | $231 | Laboratory & hospital supplies | National Institutes of Health | 6/16/2009 |
FISHER SCIENTIFIC COMPANY L.L.C. | $217 | Laboratory & hospital supplies for New England Medical Center | National Institutes of Health | 12/02/2009 |
FISHER SCIENTIFIC COMPANY L.L.C. | $214 | Laboratory & hospital supplies for New England Medical Center | National Institutes of Health | 12/04/2009 |
FISHER SCIENTIFIC COMPANY L.L.C. | $90 | Laboratory & hospital supplies for New England Medical Center | National Institutes of Health | 12/15/2009 |
FISHER SCIENTIFIC COMPANY L.L.C. | $47 | New England Med CTR Hospital Laboratory Supplies | National Institutes of Health | 12/15/2009 |
FISHER SCIENTIFIC COMPANY L.L.C. | $28 | New England Med CTR Hospital Laboratory Supplies | National Institutes of Health | 12/15/2009 |
ALLEGHENY, COUNTY OF | $0 |
ARRA - Head Start Head Start 2009 ARRA COLA Quality Improvement funding will be used to increase Head Start Salaries and Fringe Benefits for 226 staff over a 12 month period and will be given in the form of a stipend in addition to their regular salaries. We will also imp
This spending item is part of a $835,101 allocation.
See details
|
Administration for Children and Families | 5/28/2009 |
UNIVERSITY OF PITTSBURGH THE | $0 | Trans-NIH Recovery Act Research Support Proteins are fundamental molecules that perform the functions of cell, and understanding the functions of proteins is a corner stone of modern biomedical research. Much of knowledge regarding proteins is stored in the form biomedical literature. The ove | National Institutes of Health | 9/28/2010 |